Mood [affective] disorders

F5_MOOD

mood disorder: A cognitive disorder a disturbance in which the person's mood is hypothesized to be the main underlying feature.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_MANIA F5_BIPO F5_DEPRESSIO F5_PERSMOOD F5_MOODOTH	78004
6. Filter based on genotype QC (FinnGen only)	69262

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_MOOD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_MANIA\|F5_BIPO\|F5_DEPRESSIO\|F5_PERSMOOD\|F5_MOODOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mood [affective] disorders based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69262	46362	22900
Unadjusted period prevalence (%)	14.49	16.46	10.50
Median age at first event (years)	40.90	38.99	44.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
65491: Matched controls
419168

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

1173.5

323.3

377

J01EA01

ATC

trimethoprim; systemic

1.5

323.0

14296

66276

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

18.7

322.8

348

120

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

322.3

3366

10327

ZXY61

NOMESCO Finland

2-person team, special workers

34.6

322.2

291

P17

ICPC

Tobacco abuse

3.9

321.3

1096

1802

R07.3

ICD-10 Finland

Other chest pain

1.8

321.1

5996

22486

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

321.1

4346

14691

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

320.2

6293

23956

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.4

319.9

1371

2653

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

23.8

319.8

318

IEY15

NOMESCO Finland

Acute psychiatry, stabilising intervention

26.6

317.8

306

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

317.6

2868

8281

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

317.3

2526

6894

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

316.6

13766

63546

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

315.4

6599

25567

C07AB07

ATC

bisoprolol; oral

1.4

314.3

25431

131494

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

313.0

8757

36619

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

311.0

19860

98544

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

309.8

8986

37898

N05AX13

ATC

paliperidone; systemic

8.1

309.6

517

409

TAB00

NOMESCO Finland

Lumbar puncture

2.3

308.7

2679

7601

R11

ICD-10 Finland

Nausea and vomiting

2.3

307.7

6080

18141

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

33.4

307.7

431

F61.0

ICD-10 Finland

Mixed personality disorders

48.0

307.7

2872

400

N03AG01

ATC

valproic acid; systemic, rectal

8.5

307.7

7941

6710

N76.0

ICD-10 Finland

Acute vaginitis

2.1

307.7

4355

13525

N05AH03

ATC

olanzapine; systemic

14.6

307.7

10728

5536

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

25.4

307.7

1552

400

F99

ICD-10 Finland

Mental disorder, not otherwise specified

12.1

307.7

2699

1482

N05BA02

ATC

chlordiazepoxide; systemic

7.0

307.7

2186

2053

F84.5

ICD-10 Finland

Asperger syndrome

9.6

307.7

722

485

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

307.7

3370

10029

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

307.7

7347

28377

N06AX03

ATC

mianserin; oral

9.6

307.7

6005

4351

Z72.2

ICD-10 Finland

Drug use

10.4

307.7

586

364

A01

ICPC

Pain general/multiple sites

2.4

307.7

7293

20430

N06AA22, ,

ATC

12.8

307.7

607

306

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

8.0

307.7

718

579

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

307.7

30690

143147

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

14166

56443

P72

ICPC

Schizophrenia

6.3

307.7

1772

1848

F30.0

ICD-10 Finland

Hypomania

95.4

307.7

400

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

5.6

307.7

5162

6313

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

7.8

307.7

5101

4495

F50.8

ICD-10 Finland

Other eating disorders

12.3

307.7

455

238

F32.0

ICD-10 Finland

Mild depressive episode

5.5

307.7

3021

3641

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

307.7

2372

3834

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

11.8

307.7

1394

768

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

22.1

307.7

2732

823

F34.1

ICD-10 Finland

Dysthymia

43.2

307.7

7177

1190

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

8809

30504

IHZ05, ,

SPAT

4.7

307.7

5119

7412

N03AX11

ATC

topiramate; oral

4.3

307.7

2050

3098

N01

ICPC

Headache

2.2

307.7

8884

27480

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

26.2

307.7

3435

884

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

24573

108626

M01AE02

ATC

naproxen; oral, rectal

1.4

307.7

34609

182989

F29

ICD-10 Finland

Unspecified nonorganic psychosis

11.9

307.7

5218

3018

N05AB01

ATC

dixyrazine; systemic

8.7

307.7

1092

818

F43.00

ICD-10 Finland

Acute stress reaction mild

3.5

307.7

1973

3661

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

27.2

307.7

557

132

IDY02

NOMESCO Finland

Systematic individual therapy, cognitive

39.5

307.7

301

P25

ICPC

Phase of life problem adult

3.1

307.7

3606

7661

L12

ICPC

Hand/finger symptom/complaint

1.7

307.7

10867

44675

S29

ICPC

Skin symptom/complaint other

1.6

307.7

12272

52701

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

31.3

307.7

480

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

7.1

307.7

1657

1524

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

46.1

307.7

19602

3848

IBA03

NOMESCO Finland

Psychotherapy evaluation

28.1

307.7

1331

309

AA400

NOMESCO Finland

Electroconvulsive therapy

85.8

307.7

1262

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.2

307.7

1934

1132

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

25.4

307.7

2824

743

N05AH02

ATC

clozapine; systemic

6.9

307.7

1866

1775

D01

ICPC

Abdominal pain/cramps general

2.1

307.7

8919

29681

N06AB08

ATC

fluvoxamine; oral

8.6

307.7

2898

2256

IHZ04, ,

SPAT

7.2

307.7

2021

1841

N03AF02

ATC

oxcarbazepine; oral

2.7

307.7

2070

4979

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

307.7

15555

71482

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

24.9

307.7

869

226

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

17547

69636

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

307.7

2100

4789

P98

ICPC

Psychosis NOS/other

11.0

307.7

737

432

N05BA01

ATC

diazepam; systemic, rectal

4.5

307.7

13101

21859

WX290

NOMESCO Finland

Other blockage of nerve

1.7

307.7

32931

153748

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

307.7

2695

6303

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.6

307.7

4675

8779

N06AX26

ATC

vortioxetine; oral

8.9

307.7

11816

10110

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

307.7

3177

6606

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

307.7

18259

85795

Z73.0

ICD-10 Finland

Burn-out

2.5

307.7

2813

7415

Z2221

NOMESCO Finland

Medical doctor

1.7

307.7

16914

69897

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

27.2

307.7

351

N05AX15

ATC

cariprazine; oral

29.3

307.7

625

138

SPAT1254

SPAT

Administration of medicine

1.9

307.7

9140

33279

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

8.7

307.7

613

453

P99

ICPC

Psychological disorders other

12.0

307.7

4601

2629

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

16.6

307.7

797

311

P03

ICPC

Feeling depressed

7.3

307.7

15113

16536

N05CD02

ATC

nitrazepam; oral

4.7

307.7

1082

1501

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

307.7

3000

7929

F41.01

ICD-10 Finland

Severe panic disorder

16.7

307.7

709

274

F34.0

ICD-10 Finland

Cyclothymia

49.6

307.7

546

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

307.7

11946

49700

N06AX17

ATC

milnacipran; oral

14.0

307.7

1230

572

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

12.2

307.7

1040

552

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

270.3

307.7

5424

140

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.4

307.7

1633

1142

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

307.7

7215

20798

-1, ,

NOMESCO Finland

1.6

307.7

21159

97659

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

21.8

307.7

380

112

N07BB01

ATC

disulfiram; oral

7.8

307.7

5358

4727

M03BX02

ATC

tizanidine; oral

1.5

307.7

38382

202809

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

24.7

307.7

544

142

K59.0

ICD-10 Finland

Constipation

2.2

307.7

3357

10083

F32.8

ICD-10 Finland

Other depressive episodes

23.1

307.7

2508

721

IGV01

NOMESCO Finland

Psychiatric network contact

17.3

307.7

1412

533

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

14396

59180

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

307.7

7097

18591

R74

ICPC

Upper respiratory infection acute

1.7

307.7

22888

102493

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

307.7

22927

110316

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

26.6

307.7

5389

1407

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

17.0

307.7

578

219

SPAT1260

SPAT

Consultation of another employee

1.7

307.7

10330

41478

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

6.6

307.7

6502

6936

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

52.4

307.7

9282

1317

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

75.4

307.7

2972

264

M54.5

ICD-10 Finland

Low back pain

1.8

307.7

25193

106976

IER01

NOMESCO Finland

Psychoeducation, group

25.6

307.7

1004

255

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.3

307.7

1104

1362

F50.2

ICD-10 Finland

Bulimia nervosa

13.7

307.7

683

323

F60.1

ICD-10 Finland

Schizoid personality disorder

27.2

307.7

326

SPAT1389

SPAT

Visit based on need for special support

3.3

307.7

1626

3219

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

30.2

307.7

422

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

307.7

6727

23730

IEY01

NOMESCO Finland

Psychoeducation, individual

26.6

307.7

1157

283

N05AX16

ATC

brexpiprazole; oral

19.2

307.7

450

151

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

19493

93877

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

41.0

307.7

635

100

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

47442

249686

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

307.7

16965

72422

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

24.1

307.7

7837

2353

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

30043

151336

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

17.8

307.7

660

239

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

27141

121414

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

22.9

307.7

1259

359

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

25.3

307.7

884

227

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

9612

32286

F60.7

ICD-10 Finland

Dependent personality disorder

55.5

307.7

550

ZXY60

NOMESCO Finland

2-person team, nurses

19.3

307.7

685

229

Z06

ICPC

Unemployment problem

5.9

307.7

784

852

A02BC02

ATC

pantoprazole; systemic

1.7

307.7

42757

220440

N05CF01

ATC

zopiclone; oral

3.3

307.7

27247

73956

X23

ICPC

Fear sexually transm dis female

2.2

307.7

3379

10243

N05AA02

ATC

levomepromazine; systemic

13.1

307.7

5567

2954

Z91.5

ICD-10 Finland

Personal history of self-harm

43.6

307.7

413

Z72.1

ICD-10 Finland

Alcohol use

5.8

307.7

1104

1229

F10.20

ICD-10 Finland

Alcohol dependence currently independent

13.8

307.7

2728

1319

F41.1

ICD-10 Finland

Generalized anxiety disorder

8.6

307.7

7956

6622

IGY02

NOMESCO Finland

Psychiatric monitoring contact

18.6

307.7

5302

1980

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.0

307.7

1052

978

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

28.3

307.7

405

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

25.3

307.7

5747

1590

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

9.9

307.7

830

541

D06

ICPC

Abdominal pain localized other

1.9

307.7

5706

20258

R4140

NOMESCO Finland

Psychotherapy

20.9

307.7

740

229

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

267.7

307.7

3598

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.7

307.7

896

758

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

31.1

307.7

367

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

13.5

307.7

404

192

F32.9

ICD-10 Finland

Depressive episode, unspecified

35.7

307.7

30091

9752

N03AE01

ATC

clonazepam; systemic

5.0

307.7

5436

7526

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

57.2

307.7

567

L01

ICPC

Neck symptom/complaint

1.8

307.7

10572

41131

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

87.6

307.7

2376

180

F60.8

ICD-10 Finland

Other specific personality disorders

37.1

307.7

942

165

N02BF01

ATC

gabapentin; oral

2.0

307.7

6667

22208

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

307.7

4515

12303

ICB01, ,

SPAT

6.6

307.7

847

828

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

307.7

2412

6019

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

47.6

307.7

443

N05AL01

ATC

sulpiride; systemic

10.7

307.7

1518

931

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

307.7

8023

30199

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

7.4

307.7

1250

1097

F61

ICD-10 Finland

Mixed and other personality disorders

24.5

307.7

621

164

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

47.8

307.7

767

104

N06BA12

ATC

lisdexamfetamine; oral

6.8

307.7

1126

1068

T82

ICPC

Obesity

2.9

307.7

3246

7509

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

22.2

307.7

1116

327

F32.1

ICD-10 Finland

Moderate depressive episode

10.8

307.7

9787

6681

Z2445

NOMESCO Finland

Psychologist

8.3

307.7

4922

4075

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

29.0

307.7

2655

609

N05AD01

ATC

haloperidol; systemic

4.6

307.7

2484

3536

N89

ICPC

Migraine

2.6

307.7

2634

6669

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

307.7

11977

46235

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

307.7

16139

73328

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.8

307.7

4433

5190

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

14.2

307.7

518

235

T74.1

ICD-10 Finland

Physical abuse

4.7

307.7

1703

2355

Z00.0

ICD-10 Finland

General medical examination

1.6

307.7

11462

49317

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.2

307.7

4264

6849

N06AX22

ATC

agomelatine; oral

17.3

307.7

3656

1425

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

307.7

18482

83918

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

24599

120431

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

307.7

26312

107031

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.2

307.7

1158

1782

C07AA05

ATC

propranolol; systemic

3.0

307.7

17584

46076

SPAT1235

SPAT

Mental health, emotional support

7.6

307.7

649

553

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

307.7

3350

8484

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

324.4

307.7

949

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

307.7

654

A02BC05

ATC

esomeprazole; systemic

1.5

307.7

23878

115507

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

14.9

307.7

402

174

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

51.6

307.7

1627

207

A99

ICPC

Disease/condition unspecnature/site

1.8

307.7

6179

22917

K04.08

ICD-10 Finland

Other specified pulpit

2.0

307.7

5384

17621

S06.0

ICD-10 Finland

Concussion

2.2

307.7

7610

23799

SPAT1312

SPAT

General health counselling

1.5

307.7

18904

89707

Z2446

NOMESCO Finland

Social worker

4.9

307.7

6454

9165

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

307.7

4649

13212

SFA30

NOMESCO Finland

Three-surface restoration

1.5

307.7

25705

125720

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

16410

70484

N05AD03

ATC

melperone; systemic

6.8

307.7

995

948

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

22.2

307.7

3268

988

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4191.2

307.7

1927

F40.1

ICD-10 Finland

Social phobias

11.1

307.7

3481

2107

N06AA10

ATC

nortriptyline; systemic

4.0

307.7

1552

2501

N06AA09

ATC

amitriptyline; systemic

3.7

307.7

7972

14988

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

23.8

307.7

638

173

R52.9

ICD-10 Finland

Pain, unspecified

2.0

307.7

6822

23452

P58

ICPC

Psychological, Therapeutic counselling/listening

3.6

307.7

1711

3100

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

25.9

307.7

694

173

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

307.7

8610

33588

SPAT1241

SPAT

Extensive assessment of psychosocial situation

6.6

307.7

1178

1157

K08.3

ICD-10 Finland

Retained dental root

2.0

307.7

4642

15452

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

20.0

307.7

389

125

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

307.7

5643

15147

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

18.2

307.7

357

126

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

20.0

307.7

828

268

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.5

307.7

8435

17138

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

307.7

24554

124080

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

307.7

8359

32027

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

12027

45447

IBA01, ,

SPAT

4.6

307.7

1888

2696

F33

ICD-10 Finland

Recurrent depressive disorder

14.1

307.7

3507

1672

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

307.7

14047

59404

F22.0

ICD-10 Finland

Delusional disorder

7.0

307.7

1354

1265

N05BA12

ATC

alprazolam; oral

4.6

307.7

9902

15702

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

307.7

6675

21774

F41.09

ICD-10 Finland

UNS Panic Syndrome

6.3

307.7

3286

3502

ZY010

NOMESCO Finland

Hospital outpatient

9.1

307.7

7126

5574

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

18.4

307.7

549

192

P01AB01

ATC

metronidazole; oral, rectal

1.6

307.7

24608

114671

N06AX12

ATC

bupropion; oral

12.8

307.7

12741

7757

SPAT1227

SPAT

Substance abuse rehabilitation

7.9

307.7

627

511

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

307.7

12691

55445

N02BE01

ATC

paracetamol; systemic, rectal

1.8

307.7

56638

327999

X84

ICD-10 Finland

Intentional self-harm by unspecified means

22.9

307.7

367

103

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

307.7

27516

134773

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

9.4

307.7

14931

12774

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

9.1

307.7

524

370

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

36.7

307.7

552

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

23854

113011

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

19460

84902

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

7.1

307.7

1381

1274

F30.9

ICD-10 Finland

Manic episode, unspecified

174.0

307.7

459

Z08

ICPC

Social welfare problem

6.7

307.7

1277

1237

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.4

307.7

531

363

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

14.9

307.7

390

169

E66.8

ICD-10 Finland

Other obesity

2.9

307.7

4428

10101

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

307.7

9244

37588

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

37820

194463

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

307.7

32763

172863

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

8.4

307.7

695

535

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.3

307.7

1963

1767

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.4

307.7

1257

1839

R21

ICPC

Throat symptom/complaint

1.7

307.7

15007

61542

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

27335

125846

IHZ05

NOMESCO Finland

Therapeutic conversation

10.4

307.7

523

325

KMAK, ,

NOMESCO Finland

1.6

307.7

32136

160199

ZXY52

NOMESCO Finland

2-person team, doctor-psychologist

31.2

307.7

340

IAB01, ,

SPAT

10.3

307.7

665

418

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

16.5

307.7

837

328

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

50.2

307.7

475

N05BA06

ATC

lorazepam; systemic, sublingual

5.7

307.7

5085

6099

N06AB06

ATC

sertraline; oral

8.9

307.7

17117

16072

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

10.9

307.7

551

326

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

44515

234947

N06AX05

ATC

trazodone; oral

13.0

307.7

3295

1695

D09

ICPC

Nausea

2.5

307.7

3489

9150

F93.89

ICD-10 Finland

Other childhood emotional disorders

14.7

307.7

777

342

P01

ICPC

Feeling anxious/nervous/tense

4.6

307.7

15774

27063

N05CF02

ATC

zolpidem; oral

3.0

307.7

14648

37079

N05BA04

ATC

oxazepam; oral

5.4

307.7

29409

54905

A29

ICPC

General symptom/complaint other

1.7

307.7

7730

30606

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

18.8

307.7

496

170

ZXY49

NOMESCO Finland

Other health care provider

17.2

307.7

596

224

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

15.2

307.7

485

206

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

27.0

307.7

4269

1078

N30.0

ICD-10 Finland

Acute cystitis

1.6

307.7

10302

43057

P06

ICPC

Sleep disturbance

2.8

307.7

11366

28948

N05CD07

ATC

temazepam; oral

4.3

307.7

10420

17711

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

307.7

4659

15347

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

25.2

307.7

6098

1699

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.9

307.7

2086

3474

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.4

307.7

1321

1953

N05AC02

ATC

thioridazine; oral

6.1

307.7

1723

1851

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.5

307.7

1670

2002

OAB38, ,

SPAT

3.2

307.7

1657

3375

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

12.2

307.7

612

325

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

19081

86353

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

11019

40405

N06AX21

ATC

duloxetine; oral

6.0

307.7

14783

19408

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

36211

181303

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

16.9

307.7

1228

474

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

307.7

8951

26176

F31

ICD-10 Finland

Bipolar affective disorder

123.4

307.7

2235

120

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

6.9

307.7

891

840

D11

ICPC

Diarrhoea

2.1

307.7

8887

28771

IAB11

NOMESCO Finland

Psychiatric mood consultation

20.0

307.7

385

124

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

60.5

307.7

329

F43.1

ICD-10 Finland

Post-traumatic stress disorder

9.5

307.7

3533

2512

F41

ICD-10 Finland

Other anxiety disorders

3.6

307.7

1393

2510

L28

ICPC

Limited function/disability (L)

1.8

307.7

11006

41462

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

307.7

5943

16444

IHZ07, ,

SPAT

7.8

307.7

731

608

N06AA06

ATC

trimipramine; systemic

7.6

307.7

2389

2071

A05

ICPC

Feeling ill

2.3

307.7

4503

13236

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

37.3

307.7

5016

931

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

20.2

307.7

498

159

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

17.7

307.7

872

319

T36

ICD-10 Finland

Poisoning by systemic antibiotics

19.1

307.7

7331

2743

N05AA01

ATC

chlorpromazine; systemic, rectal

9.2

307.7

1302

920

N05AX08

ATC

risperidone; systemic

6.4

307.7

9773

11189

P74

ICPC

Anxiety disorder/anxiety state

7.4

307.7

6154

5761

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

10.6

307.7

3032

1911

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

32.6

307.7

2440

497

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

307.7

3724

10586

F21

ICD-10 Finland

Schizotypal disorder

14.8

307.7

670

292

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

307.7

1466

1608

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

36387

177025

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

537.0

307.7

500

A02BC03

ATC

lansoprazole; oral

1.6

307.7

16185

71087

P73

ICPC

Affective psychosis

34.2

307.7

671

127

N06AA04

ATC

clomipramine; systemic

8.5

307.7

1703

1315

F39

ICD-10 Finland

Unspecified mood [affective] disorder

31.4

307.7

3085

658

N05AF03

ATC

chlorprothixene; systemic

15.4

307.7

3667

1610

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

15.8

307.7

765

313

F50.0

ICD-10 Finland

Anorexia nervosa

8.7

307.7

621

460

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

19262

66175

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.8

307.7

14817

17219

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

48471

252781

SPAT1216

SPAT

Assessment of functional ability

1.7

307.7

7935

31355

N06AB04

ATC

citalopram; systemic

7.3

307.7

26626

36024

N06AB05

ATC

paroxetine; oral

6.9

307.7

7213

7376

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

18.6

307.7

490

170

R06.0

ICD-10 Finland

Dyspnoea

1.8

307.7

16708

68547

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.5

307.7

1139

873

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

18629

82477

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

307.7

26559

129374

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

307.7

12614

49272

R52.2

ICD-10 Finland

Other chronic pain

3.4

307.7

2852

5574

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.4

307.7

1810

2178

P28

ICPC

Limited function/disability (P)

9.8

307.7

862

572

H01

ICPC

Ear pain/earache

1.8

307.7

7765

29442

N03AX12

ATC

[U] gabapentin; oral

2.4

307.7

11546

33748

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.4

307.7

8009

8893

F50.9

ICD-10 Finland

Eating disorder, unspecified

11.6

307.7

1116

627

D10

ICPC

Vomiting

2.3

307.7

4403

12597

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

11671

44940

P19

ICPC

Drug abuse

7.4

307.7

984

862

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

307.7

673

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

82.9

307.7

15768

1597

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

14.3

307.7

444

200

N06AB10

ATC

escitalopram; oral

7.0

307.7

27978

40109

N06AX16

ATC

venlafaxine; oral

11.3

307.7

23311

19495

F41.00

ICD-10 Finland

Moderate panic disorder

12.7

307.7

1971

1018

A04

ICPC

Weakness/tiredness general

2.2

307.7

11937

37952

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.1

307.7

975

1036

ZXD05

NOMESCO Finland

Urgent procedure

1.5

307.7

16970

80929

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

25.6

307.7

1268

323

OAA68, ,

SPAT

3.8

307.7

1172

1992

N03AX09

ATC

lamotrigine; oral

16.3

307.7

8148

3627

R42

ICD-10 Finland

Dizziness and giddiness

1.7

307.7

14036

57577

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

307.7

11840

48452

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

20.1

307.7

558

179

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

307.7

5648

19631

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

15244

57792

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

307.7

4025

10558

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

22.8

307.7

579

164

N05AF05

ATC

zuclopenthixol; systemic

6.9

307.7

839

790

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

307.7

7997

31564

SPAT1234

SPAT

Support of social functional capacity

3.0

307.7

3340

7471

OAB93, ,

SPAT

2.0

307.7

4608

14935

M25.5

ICD-10 Finland

Pain in joint

1.5

307.7

20418

95265

X78

ICD-10 Finland

Intentional self-harm by sharp object

17.5

307.7

687

254

N05AE04

ATC

ziprasidone; systemic

23.0

307.7

825

232

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.3

307.7

1662

2045

F60.9

ICD-10 Finland

Personality disorder, unspecified

44.1

307.7

2083

312

F50.1

ICD-10 Finland

Atypical anorexia nervosa

11.6

307.7

531

296

F51.0

ICD-10 Finland

Nonorganic insomnia

3.0

307.7

15655

40212

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

23615

100493

F43.0

ICD-10 Finland

Acute stress reaction

2.1

307.7

3800

12078

N06AG02

ATC

moclobemide; oral

8.5

307.7

5102

4139

N04AA02

ATC

biperiden; systemic

7.7

307.7

1906

1618

P18

ICPC

Medication abuse

12.3

307.7

722

381

L03

ICPC

Low back symptom/complaint

1.8

307.7

19847

81497

P15

ICPC

Chronic alcohol abuse

6.3

307.7

3342

3521

R51.80

ICD-10 Finland

Headache

2.3

307.7

12226

37830

F10.24

ICD-10 Finland

Alcohol depence active use

10.4

307.7

1797

1131

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

8.7

307.7

2199

1666

SPAT1243

SPAT

Psychiatric/psychological examination

6.0

307.7

2849

3173

N06BA04

ATC

methylphenidate; oral

5.9

307.7

3941

4480

IGY02, ,

SPAT

10.7

307.7

2086

1282

IGP01

NOMESCO Finland

Psychiatric family contact

13.1

307.7

892

441

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

8731

30528

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

95.3

307.7

1069

F31.8

ICD-10 Finland

Other bipolar affective disorders

200.6

307.7

3530

119

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

38.4

307.7

794

134

N06AB03

ATC

fluoxetine; oral

7.4

307.7

16061

17581

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

307.7

6464

18143

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

286.7

307.7

3599

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

307.7

14512

64038

F50.3

ICD-10 Finland

Atypical bulimia nervosa

14.8

307.7

505

220

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

307.7

5063

15081

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.5

307.7

4668

9101

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

11.9

307.7

708

386

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

307.7

20297

83933

N17

ICPC

Vertigo/dizziness

1.7

307.7

7340

28667

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

307.7

10741

45251

A97

ICPC

No disease

1.6

307.7

12341

52525

N03AF01

ATC

carbamazepine; oral, rectal

2.9

307.7

3285

7390

P02

ICPC

Acute stress reaction

2.3

307.7

3942

11408

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

44.7

307.7

5308

826

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

307.7

8348

31771

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

307.7

16393

71781

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

81.7

307.7

12880

1252

P29

ICPC

Psychological sympt/compl other

5.8

307.7

9941

12455

N05AX12

ATC

aripiprazole; systemic

21.8

307.7

7397

2437

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

152.7

307.7

1515

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

132.1

307.7

10846

629

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

20.4

307.7

526

166

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.1

307.7

3697

11555

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

307.7

5058

16300

N05BE01

ATC

buspirone; oral

12.7

307.7

3999

2135

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

22.2

307.7

414

120

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

61.5

307.7

1106

117

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

307.7

31841

166443

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

307.7

16132

71435

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

11.1

307.7

900

524

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.8

307.7

3219

7557

ICB06, ,

NOMESCO Finland

28.6

307.7

1052

239

N07BA03

ATC

varenicline; oral

2.4

307.7

3221

8972

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.6

307.7

1111

950

A02BA02

ATC

ranitidine; systemic

1.6

307.7

10042

41578

F60.0

ICD-10 Finland

Paranoid personality disorder

38.8

307.7

488

N02BF02

ATC

pregabalin; oral

3.0

307.7

5394

12207

IGY99, ,

SPAT

4.3

307.7

1950

2954

A06AD11

ATC

lactulose; oral

2.1

307.7

8873

28618

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

2855.2

307.7

893

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

404.5

307.7

2434

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

15.7

307.7

698

287

P76

ICPC

Depressive disorder

13.4

307.7

11863

6826

SPAT1265

SPAT

Breathalyser

6.3

307.7

814

833

A03

ICPC

Fever

1.6

307.7

11276

47570

R06AE07

ATC

cetirizine; oral

1.5

307.7

27231

135905

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

16187

65107

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

17.0

307.7

5519

2251

N06AA12

ATC

doxepin; systemic

6.0

307.7

5061

5739

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

35379

174584

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.1

307.7

1808

1472

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

21.0

307.7

414

127

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

64.2

307.7

4446

475

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

6.2

307.7

13652

17197

J01FF01

ATC

clindamycin; systemic

1.5

307.7

15404

71984

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

8256

28921

ZXY56

NOMESCO Finland

2-person team, nurse-psychologist

24.0

307.7

377

101

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

307.7

948

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

307.7

8129

29154

IEY03

NOMESCO Finland

Vocational rehabilitation

48.3

307.7

427

R96

ICPC

Asthma

1.8

307.7

5862

21249

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

12445

46123

J01DA01

ATC

[U] cefalexin

1.5

307.7

36932

197527

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

307.7

5125

17517

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

7.4

307.7

905

789

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

17796

73057

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.5

307.7

882

1033

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

307.7

3414

10352

N05AN01

ATC

lithium; oral

40.9

307.7

4227

706

SGA01

NOMESCO Finland

Emergency treatment

1.7

307.7

10555

42372

P27

ICPC

Fear of mental disorder

7.8

307.7

1424

1187

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.8

307.7

4269

7478

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

15.3

307.7

560

236

IAA01, ,

SPAT

5.6

307.7

808

934

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.8

307.7

2022

2278

SPAT1284

SPAT

Extensive health certificate

3.2

307.7

1946

4009

IAZ99

NOMESCO Finland

Other psychiatric consultation

14.2

307.7

422

191

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

19183

75637

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

8.7

307.7

583

434

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

307.7

15413

71781

A02BC01

ATC

omeprazole; systemic

1.6

307.7

15967

69214

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

9083

32649

N06AX18

ATC

reboxetine; oral

14.4

307.7

1254

567

N03AX16

ATC

[U] pregabalin

2.6

307.7

17460

51429

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.2

307.7

2216

4543

F60.5

ICD-10 Finland

Anankastic personality disorder

19.7

307.7

1539

511

SPAT1301

SPAT

No procedures

1.6

307.7

18560

83409

H02AB06

ATC

prednisolone; systemic

1.4

307.7

27373

142173

P16

ICPC

Acute alcohol abuse

6.6

307.7

1633

1629

K10.3

ICD-10 Finland

Alveolitis of jaws

2.3

307.7

3226

9431

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

307.7

3595

8434

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.8

307.7

1280

2195

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

443.4

307.7

482

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

14007

57731

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

13.3

307.7

4769

2454

SPAT1307

SPAT

Psychosocial counselling and guidance

4.5

307.7

6672

10210

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.3

307.7

1778

3535

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

307.7

854

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.0

307.7

4297

14427

F33.8

ICD-10 Finland

Other recurrent depressive disorders

44.5

307.7

1362

200

ZY000

NOMESCO Finland

Hospital inpatient

16.0

307.7

1715

705

V03AA01, ,

ATC

6.5

307.7

1356

1352

ZXY03

NOMESCO Finland

Occupational therapist

21.8

307.7

383

113

A28

ICPC

Limited function/disability NOS

1.7

307.7

8984

36161

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.3

307.7

1681

1072

P80

ICPC

Personality disorder

33.3

307.7

660

128

J01CA08

ATC

pivmecillinam; oral

1.4

307.7

23357

117618

SPAT1238

SPAT

Brief therapy

4.2

307.7

1430

2213

F32

ICD-10 Finland

Depressive episode

8.5

307.7

7917

6695

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

307.7

4164

12036

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

634.5

307.7

1454

J01DB01

ATC

cefalexin; oral

1.5

307.7

52021

299645

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

307.7

16078

65428

F41.8

ICD-10 Finland

Other specified anxiety disorders

5.0

307.7

3426

4618

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

307.7

26669

130606

F10.25

ICD-10 Finland

Alcohol dependence continuous use

8.9

307.7

1970

1456

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

17.0

307.7

391

148

IAA02

NOMESCO Finland

Consultation concerning further psychiatric treatment

21.6

307.7

372

111

IGY99

NOMESCO Finland

Other psychiatric treatment contact

22.9

307.7

3464

1019

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

7.8

307.7

846

705

R4110

NOMESCO Finland

Physiotherapy

1.5

307.7

15802

72027

M79.7

ICD-10 Finland

Fibromyalgia

4.7

307.7

3239

4588

Z29

ICPC

Social problem NOS

3.6

307.7

1639

2957

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

307.7

5362

10759

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

307.7

4016

12103

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

307.7

6595

22168

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

9.5

307.7

876

596

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

8.3

307.7

982

768

U02

ICPC

Urinary frequency/urgency

1.6

307.7

8620

35267

L02

ICPC

Back symptom/complaint

1.9

307.7

6944

24230

F41.3

ICD-10 Finland

Other mixed anxiety disorders

6.6

307.7

1732

1719

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.3

307.7

4854

7689

N05AE05

ATC

lurasidone; oral

36.6

307.7

579

102

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

28008

133238

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

1863

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

38.8

307.7

702

117

F43.8

ICD-10 Finland

Other reactions to severe stress

2.8

307.7

2012

4701

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.6

307.7

805

929

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.7

307.7

4224

3281

ICA04

NOMESCO Finland

Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution

31.8

307.7

312

N06AX11

ATC

mirtazapine; oral

6.1

307.7

38345

79248

N05AH04

ATC

quetiapine; oral

11.6

307.7

28686

26413

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

12300

55316

1.52

321.11

3.4

3.0

3.85

2.92

e6/l

7.31

5664

26656

(3023323) Follitropin [Units/volume] in Serum or Plasma

5508

20155

1.82

319.74

1.5

1.4

23.17

26.43

iu/l

10.80

4509

17452

(3024354) Oxygen [Partial pressure] in Venous blood

7018

27576

1.70

319.16

3.8

3.3

4.75

4.56

kpa

8.89

6778

26890

(40768797) Stomach Pathology biopsy report

10738

47264

1.54

307.66

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2004

939

14.06

307.65

2.1

2.3

—

(3001604) Monocytes [#/volume] in Blood

38011

181374

1.81

307.65

7.3

6.3

0.57

0.58

e9/l

7.61

32709

157265

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

21733

88612

1.85

307.65

2.5

2.3

2.73

2.79

mg/l

3.07

18866

76862

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

25837

109959

1.83

307.65

3.2

2.6

57.30

68.21

u/l

1.24

23905

102268

(3002582) Erythrocytes [#/volume] in Urine

23839

112005

1.57

307.65

3.8

3.3

50.78

83.23

e6/l

5.36

18150

84854

(3013650) Neutrophils [#/volume] in Blood by Automated count

41424

202986

1.83

307.65

11.4

9.4

4.16

4.09

e9/l

6.69

35952

176718

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

59904

353895

1.98

307.65

20.2

14.5

21.64

23.82

mg/l

50.50

51123

288038

(3032080) INR in Blood by Coagulation assay

30071

155314

1.44

307.65

12.8

13.7

1.17

1.24

inr

74.95

25119

129473

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

17796

39129

3.62

307.65

2.3

1.6

1.55

1.39

127.55

15861

34778

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

15637

64004

1.74

307.65

2.7

3.0

2.44

2.45

mmol/l

14.32

13881

57500

(40758558) Short blood count panel - Blood

22279

104871

1.55

307.65

7.2

6.3

—

(3042517) Benzodiazepines panel - Urine

474

150

20.37

307.65

2.8

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12930

54999

1.63

307.65

2.1

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

60914

352699

2.51

307.65

22.8

16.6

139.52

139.68

mmol/l

47.10

60068

345642

(3019150) Specific gravity of Urine by Refractometry

18538

83119

1.60

307.65

4.4

3.8

1.10

1.13

kg/l

0.11

12081

54570

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

54427

274894

2.58

307.65

5.6

4.2

14.47

14.73

pmol/l

118.98

51020

253915

(3001122) Ferritin [Mass/volume] in Serum or Plasma

36816

175709

1.78

307.65

3.7

3.1

102.23

118.85

ug/l

27.84

34491

165538

(3019198) Lymphocytes [#/volume] in Blood

38628

186025

1.80

307.65

7.4

6.3

1.99

1.91

e9/l

14.47

34022

164975

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

13698

48891

2.00

307.65

2.6

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

11536

45500

1.76

307.65

1.8

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

27655

114225

1.95

307.65

3.1

3.6

2.35

mmol/l

1.17

25343

104527

(3009261) Glucose [Presence] in Urine by Test strip

36527

194687

1.45

307.65

4.5

3.7

0.43

0.22

estimate

0.41

7340

38028

(3019309) Folate [Moles/volume] in Red Blood Cells

15167

49972

2.23

307.65

1.8

1.7

1162.01

1162.51

nmol/l

0.02

11904

37971

(36660697) Celiac disease serology panel - Serum

7638

29362

1.75

307.65

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

33644

151703

1.86

307.65

5.3

5.1

36.29

35.95

g/l

22.45

31605

142503

(3003458) Phosphate [Moles/volume] in Serum or Plasma

11195

43584

1.78

307.65

6.3

1.04

mmol/l

0.54

10478

40628

(3037522) Nuclear Ab [Titer] in Serum

11938

51254

1.60

307.65

1.4

459.74

539.89

titre

4.81

2241

10746

(3000850) Epithelial cells [#/volume] in Urine

16739

76410

1.54

307.65

3.0

2.7

6.68

5.58

e6/l

15.66

15242

69458

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25351

128030

1.44

307.65

4.3

3.5

48.98

60.92

ng/l

0.63

16348

83719

(3023511) Choriogonadotropin [Units/volume] in Urine

2813

7152

2.59

307.65

1.4

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

34435

146173

2.07

307.65

2.3

2.0

97.00

96.62

pmol/l

0.73

19298

77979

(4198724) Urine methamphetamine measurement

1446

878

10.76

307.65

2.5

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

60943

353501

2.49

307.65

22.9

16.8

3.94

3.96

mmol/l

76.83

60009

345797

(3021387) Prolactin [Units/volume] in Serum or Plasma

4790

13841

2.31

307.65

1.7

360.06

278.62

mu/l

24.58

4265

12650

(3004789) Transferrin [Mass/volume] in Serum or Plasma

12882

54877

1.63

307.65

2.7

2.6

2.40

2.35

g/l

19.93

11739

50908

(3023368) Bacteria identified in Blood by Culture

19839

91927

1.55

307.65

5.0

4.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

9307

37902

1.67

307.65

2.0

1.8

—

(3013115) Eosinophils [#/volume] in Blood

38954

187549

1.81

307.65

7.8

6.5

0.19

e9/l

1.14

34100

164985

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

3475

10269

2.23

307.65

2.1

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8192

31957

1.73

307.65

2.5

2.3

0.22

0.21

g/l

12.57

7504

29997

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

61583

373456

1.93

307.65

14.8

11.2

27.77

26.49

u/l

27.53

60347

363654

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

57725

332032

1.95

307.65

5.8

4.7

5.98

5.85

mmol/l

77.14

54206

308462

(46235355) HIV 1 and 2 tests - Meaningful Use set

18206

77858

1.69

307.65

2.3

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

12824

44730

2.04

307.65

2.5

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

23724

90983

2.05

307.65

1.8

1.7

19.80

20.17

nmol/l

3.30

21022

77750

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1437

1357

6.91

307.65

15.8

15.9

779.57

2952.49

nmol/l

1.06

1401

1303

(3012544) pH of Venous blood

8329

33668

1.67

307.65

4.4

4.0

7.38

1.55

4672

19415

(3018010) Neutrophils/Leukocytes in Blood

34632

169238

1.66

307.65

7.2

6.3

56.71

57.13

9.27

33083

162362

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

38593

180729

1.89

307.65

6.6

6.5

10.14

11.50

umol/l

83.98

36542

172251

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4712

16243

1.92

307.65

2.5

2.3

5712.34

6271.02

u/l

0.50

1533

6854

(3002030) Lymphocytes/Leukocytes in Blood

35185

172471

1.66

307.65

7.4

6.5

28.69

28.10

20.23

33341

164311

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

14349

66418

1.49

307.65

1.8

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

29296

116786

2.10

307.65

3.9

3.2

32.29

33.12

u/l

0.58

27582

110655

(3048689) Calprotectin [Mass/mass] in Stool

12240

48502

1.76

307.65

2.4

2.6

117.96

132.34

ug/g

4.70

9570

39044

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

13318

60322

1.52

307.65

3.2

2.9

1.11

e6/l

0.03

6740

31753

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16188

67721

1.70

307.65

1.8

1.7

33960639.26

36500750.87

pmol/l

0.20

13719

56868

(3033658) Prothrombin time (PT) actual/Normal

19341

87924

1.58

307.65

4.8

4.0

93.45

90.33

57.11

18808

85988

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

10046

39982

1.72

307.65

2.8

7.18

8.54

umol/l

7.65

8364

35238

(3031040) Bacteria [#/volume] in Urine by Automated count

44269

230892

1.70

307.65

5.7

4.4

1794.97

1605.90

e6/l

0.24

633

3098

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8343

33169

1.70

307.65

4.4

3.9

5.88

5.81

kpa

7.75

8089

32410

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

7200

24326

2.00

307.65

2.3

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

11760

50450

1.60

307.65

2.8

2.7

22.25

22.96

6.15

10828

47036

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

49461

260746

1.87

307.65

4.8

4.2

11.40

11.29

mm/h

0.96

46577

245342

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

57244

336207

1.71

307.65

18.2

14.0

88.25

83.65

ml/min/173m2

307.65

53230

307797

(3009508) Creatinine [Moles/volume] in Urine

25609

117055

1.66

307.65

3.8

3.4

7.74

7.79

mmol/l

0.73

21964

100207

(3023183) Ammonium ion [Moles/volume] in Plasma

2558

6497

2.58

307.65

2.9

2.7

33.55

33.89

umol/l

0.22

2336

5865

(3018418) pH of Serum or Plasma

24145

99092

1.89

307.65

4.4

4.3

7.40

1.42

17159

70400

(3014111) Lactate [Moles/volume] in Serum or Plasma

7701

29943

1.73

307.65

8.2

7.9

1.38

1.33

mmol/l

2.75

7512

29422

(3030467) Casts [#/volume] in Urine by Automated count

20919

96506

1.57

307.65

3.7

3.2

0.36

0.41

e6/l

2.72

15315

70032

(3022948) Iron [Moles/volume] in Serum or Plasma

13784

59083

1.62

307.65

2.7

2.6

13.33

13.73

umol/l

0.59

12789

55291

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1550

2374

4.26

307.65

1.7

1.4

1.43

1.25

promille

3.71

1196

1928

(3036481) Cortisol [Moles/volume] in Serum or Plasma

10232

31570

2.27

307.65

2.1

2.4

375.73

380.10

nmol/l

1.21

9422

29533

(3019069) Monocytes/Leukocytes in Blood

34637

167428

1.69

307.65

7.4

6.6

8.51

8.80

72.72

32527

157894

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

6431

22531

1.92

307.65

3.1

3.6

4.46

4.55

pmol/l

8.95

5649

20540

(3020564) Creatinine [Moles/volume] in Serum or Plasma

61866

375128

2.00

307.65

24.6

18.4

74.50

76.30

umol/l

30.48

61336

370950

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

48329

247357

1.96

307.65

4.6

3.0

49.53

45.02

u/l

18.31

45941

234393

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

55692

326959

1.60

307.65

7.1

5.8

38.94

38.76

mmol/mol

4.34

52675

308509

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

9807

40284

1.66

307.65

2.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

18224

85406

1.51

307.65

4.3

3.6

0.41

0.25

0.72

102

791

(3022096) Basophils/Leukocytes in Blood

34518

166970

1.68

307.65

7.4

6.6

0.68

1.44

32374

157167

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1057

656

10.47

307.65

2.4

2.8

140.51

162.57

nmol/l

3.51

936

569

(3006315) Basophils [#/volume] in Blood

38116

181788

1.82

307.65

7.3

6.3

0.04

e9/l

1.25

32771

157572

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14800

67255

1.53

307.65

1.4

1.3

29.41

34.14

iu/ml

2.13

3934

20789

(3026782) Osmolality of Urine

14642

64549

1.58

307.65

3.1

2.9

510.05

538.10

mosm/kgh2o

35.16

12793

56750

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1514

1436

6.88

307.65

20.7

21.7

1829.09

3174.66

nmol/l

0.50

1466

1377

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

17078

78355

1.53

307.65

2.0

1.8

1.07

1.20

mg/l

4.83

12906

60502

(3009466) Valproate [Moles/volume] in Serum or Plasma

3510

2774

8.50

307.65

6.5

4.3

372.81

357.51

umol/l

4.56

3135

2405

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

20390

85768

1.76

307.65

1.4

1.3

1.46

1.68

u/ml

1.63

5220

24335

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8948

32272

1.90

307.65

3.0

2.5

40.98

50.23

u/l

0.76

7545

27511

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

34576

148588

2.04

307.65

7.2

6.6

1.21

mmol/l

3.10

32366

137900

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

37787

167330

2.05

307.65

7.8

7.2

1.21

mmol/l

0.00

33212

144519

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5372

19285

1.85

307.65

4.4

4.2

24.27

24.20

mmol/l

0.81

5274

19070

(3018095) Leukocytes [#/volume] in Urine

27160

130326

1.57

307.65

4.6

3.8

77.78

92.56

e6/l

2.10

18941

90394

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

25940

123412

1.57

307.65

3.9

3.3

2.64

1.86

e6/l

0.47

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

34944

158033

1.89

307.65

2.8

2.4

2610.48

76.92

nmol/l

0.50

32322

144870

(3035350) Ketones [Presence] in Urine by Test strip

36447

193259

1.47

307.65

4.5

3.7

5.23

3.72

estimate

0.84

7770

39973

(42870588) Differential panel, method unspecified - Blood

26339

119069

1.70

307.65

6.8

6.5

4.80

5.67

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13917

56016

1.75

307.65

3.6

0.82

mmol/l

0.80

13080

52846

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1134

995

7.41

307.65

2.6

1.3

161.61

92.90

umol/l

6.70

583

475

(3007164) IgA [Mass/volume] in Serum or Plasma

17557

74358

1.70

307.65

1.5

2.31

2.36

g/l

2.92

10231

48055

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

23735

102645

1.75

307.65

2.6

2.1

229.76

204.79

u/l

2.00

22543

97222

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13625

61932

1.52

307.65

1.4

1.3

8.94

10.93

u/ml

2.37

4899

25200

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

59044

326253

2.61

307.65

7.1

5.0

1.79

1.87

mu/l

23.16

56160

304638

(3021601) Nitrite [Presence] in Urine by Test strip

36007

191054

1.46

307.65

4.5

3.7

0.00

estimate

0.72

7667

39245

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

8425

29299

1.96

307.65

2.5

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

7572

11942

4.46

307.65

2.0

1.6

0.30

0.31

mg/l

1.15

3687

5720

(3013826) Glucose [Moles/volume] in Serum or Plasma

40591

204046

1.72

307.65

6.2

4.9

6.62

6.65

mmol/l

1.63

38493

191914

(3021589) Normoblasts [#/volume] in Blood

31696

159003

1.53

307.65

12.7

11.0

0.00

e9/l

2.08

25580

130253

(3024666) Lithium [Moles/volume] in Serum or Plasma

2343

333

46.67

307.65

13.5

13.2

0.62

mmol/l

0.28

2180

293

(36304419) Bacteria [Presence] in Urine

20069

92094

1.57

307.65

3.6

3.1

48.94

137.55

estimate

0.51

379

(3002032) Base excess in Venous blood by calculation

8097

32286

1.69

307.65

4.4

4.0

1.76

1.77

mmol/l

0.05

7141

28456

(3006504) Eosinophils/Leukocytes in Blood

34546

166972

1.69

307.65

7.4

6.5

2.76

2.85

10.79

32426

157345

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

52155

265890

2.25

307.65

9.1

8.0

77.78

78.05

u/l

0.64

49859

253063

(3037467) Urinalysis macro (dipstick) panel - Urine

45477

243399

1.64

307.65

5.3

4.4

2.50

38.72

0.52

379

(3044889) 12 lead EKG panel

44174

239528

1.55

307.65

4.3

3.8

4964.60

2080.34

0.32

443

(3015736) pH of Urine

31176

152795

1.58

307.65

3.9

3.3

6.29

6.20

31.09

16775

86414

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2873

8507

2.21

299.54

1.3

496.63

553.32

mg/l

2.21

2747

8165

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6316

24506

1.72

299.41

1.8

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2627

7499

2.29

298.34

1.4

1.5

2413.74

1807.27

e6/l

0.16

2040

5932

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2598

7409

2.30

295.66

1.4

27.45

35.40

e6/l

0.52

1894

5508

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4898

17737

1.83

292.84

1.1

13.75

7.80

u/ml

0.32

221

(3019977) pH of Arterial blood

8962

38241

1.58

292.64

8.7

7.9

7.41

7.42

4.70

4995

20525

(3027801) Oxygen [Partial pressure] in Arterial blood

8945

38167

1.58

292.08

8.7

7.9

12.03

12.75

kpa

30.66

8633

36711

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8946

38186

1.58

291.58

8.7

7.9

5.16

5.07

kpa

15.42

8640

36743

(3003396) Base excess in Arterial blood by calculation

8878

37908

1.58

288.70

8.6

7.8

1.04

0.88

mmol/l

3.02

7419

31288

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1727

4128

2.72

282.67

1.7

413.94

359.09

mu/l

2.73

1360

3404

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2590

7524

2.25

282.21

1.2

1.3

3.79

3.71

mmol/l

2.81

2440

7140

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13742

64692

1.46

280.83

4.2

3.7

266.92

507.71

ng/l

9.98

9403

48598

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5593

21359

1.74

279.38

3.7

3.6

5.20

5.12

kpa

10.46

5381

20346

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

6565

26319

1.66

274.32

1.2

117.14

146.90

u/ml

6.66

2223

10270

(3029937) Albumin [Presence] in Urine by Test strip

20508

104014

1.38

273.75

4.8

3.9

0.00

0.01

estimate

1.41

7244

36407

(3009343) pH of Capillary blood

5440

20748

1.74

272.63

3.7

3.6

7.41

7.42

8.63

4605

17211

(3000570) Elastase.pancreatic [Mass/mass] in Stool

3086

9782

2.07

270.65

1.5

1.4

279.95

274.49

ug/g

0.56

1712

5682

(3009214) Lutropin [Units/volume] in Serum or Plasma

3501

11792

1.95

259.61

1.5

1.4

9.45

9.69

u/l

0.45

2725

9648

(3042936) Bacteria identified in Isolate by Culture

10782

49194

1.48

255.01

2.3

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4821

18091

1.76

254.75

3.5

1.63

1.74

mmol/l

1.21

3616

13138

(3016502) Oxygen saturation in Arterial blood

7947

33971

1.57

254.36

9.0

8.2

95.43

95.77

4.72

7730

32786

(3000494) Fungus identified in Specimen by Culture

9492

42543

1.50

243.72

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

9972

45151

1.49

243.69

2.0

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3414

11669

1.92

242.13

2.3

525.65

543.39

ug/l

0.08

3204

11010

(3013512) EKG study

21674

112558

1.35

240.85

3.7

3.5

0.71

0.74

0.20

261

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1734

4556

2.48

235.25

1.6

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

192

61.62

234.16

1.5

1.4

517.14

331.98

nmol/l

1.83

192

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4954

19221

1.70

231.77

1.8

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5568

22328

1.65

230.08

8.6

8.3

24.94

24.75

mmol/l

3.27

5515

22174

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

51040

301283

1.38

228.94

24.8

17.4

13.58

13.53

17.52

50534

297285

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11053

51702

1.44

226.70

2.2

29.38

29.59

3.56

10745

50310

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8348

36967

1.51

225.37

7.7

6.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6551

27485

1.58

225.16

2.6

2.9

10.33

10.65

g/l

8.26

5976

25512

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7375

31960

1.54

219.60

9.6

8.7

122.59

121.50

g/l

4.28

7246

31211

(3020779) Urea [Moles/volume] in Serum or Plasma

6947

29721

1.55

219.05

8.1

7.8

8.61

9.75

mmol/l

34.40

6652

28455

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

6278

26309

1.58

216.29

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1878

5458

2.24

203.55

1.4

1.3

22.72

26.47

u/l

4.85

1458

4585

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4905

19750

1.64

198.02

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5924

25170

1.56

190.87

4.0

4.1

87.30

89.07

ng/l

0.63

5139

21993

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18340

95385

1.32

190.13

3.1

1066.17

1322.63

ng/l

11.16

15178

81605

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3481

12912

1.77

189.40

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2672

9138

1.91

188.14

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2681

9195

1.90

187.16

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

980

2161

2.93

185.00

1.8

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

2679

9224

1.90

184.80

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4812

19606

1.62

184.74

10.4

10.1

24.34

24.25

mmol/l

1.11

4675

19189

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4320

17233

1.65

180.18

3.6

3.0

1.53

1.21

39.64

4305

17156

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

26865

147758

1.28

179.20

2.0

1.9

1.51

1.34

mmol/l

136.47

22963

125771

(3027945) Reticulocytes/Erythrocytes in Blood

8236

38009

1.44

176.83

2.6

1.81

1.76

3.87

7265

34100

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16811

87089

1.32

176.30

2.6

2.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4270

17112

1.64

174.72

3.6

2.9

0.61

0.63

1.63

4259

17061

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5148

21611

1.57

173.95

10.8

10.0

1.48

1.29

23.17

5128

21478

(3014007) Fractional oxyhemoglobin in Arterial blood

5154

21687

1.57

172.32

10.9

10.1

93.54

94.10

7.78

5141

21615

(3019225) pH of Specimen

6816

30472

1.48

171.98

4.2

4.1

7.36

0.63

5185

21678

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5004

20976

1.57

169.96

11.0

10.3

0.64

0.35

4985

20866

(21494755) Public health laboratory ask at order entry panel

4324

42106

0.63

169.75

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

3422

13044

1.72

168.76

1.7

3.94

4.28

mg/l

1.10

2853

9196

(3012516) Albumin [Mass/volume] in Urine

20309

108488

1.29

167.28

3.7

3.5

48.17

49.31

mg/l

0.26

13090

69176

(3008295) Osmolality of Serum or Plasma

1227

3234

2.46

165.06

1.7

1.4

281.45

278.46

mosm/kgh2o

3.53

899

2536

(3003181) Sodium [Moles/volume] in Urine

1803

5625

2.08

163.62

1.5

1.4

58.91

62.98

mmol/l

3.29

1376

4495

(3020891) Body temperature

3771

14886

1.66

163.22

5.3

4.4

36.95

36.90

°c

10.24

3730

14751

(3013139) Helicobacter pylori Ag [Presence] in Stool

5652

24621

1.51

161.01

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

5037

21399

1.55

160.92

1.9

1.26

1.30

g/l

0.70

4621

19794

(3020682) Albumin/Creatinine [Ratio] in Urine

20563

110451

1.28

160.38

4.4

4.2

9.53

8.49

mg/mmol

1.69

12878

69144

(3023410) Appearance of Cerebral spinal fluid

1235

3315

2.41

159.82

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3029

11323

1.75

159.79

3.0

2.9

24.78

24.64

mmol/l

1.25

2968

11120

(3004119) Hemoglobin [Mass/volume] in Venous blood

4834

20387

1.56

159.44

3.7

3.3

130.64

129.75

g/l

1.89

4686

19855

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3562

13988

1.67

157.09

1.3

0.51

0.94

u/ml

2.19

285

1074

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5704

25085

1.50

154.96

2.4

20.40

20.99

au/ml

0.20

517

3054

(3025941) Bacteria identified in Stool by Culture

4745

20100

1.55

153.22

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5316

23150

1.51

151.15

1.3

45.78

51.66

au/ml

1.06

242

1506

(3007566) Smooth muscle Ab [Titer] in Serum

2749

10160

1.76

150.61

1.2

1.3

97.73

122.12

titre

1.27

273

970

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2662

9773

1.77

149.15

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

57706

352821

1.39

148.90

6.1

5.4

2.75

2.74

mmol/l

0.56

54358

332407

(3007463) Buprenorphine [Presence] in Urine

159

18.55

147.37

7.3

10.0

—

(3017732) Neutrophils [#/volume] in Blood

9327

45330

1.37

145.84

3.6

3.0

4.50

4.48

e9/l

0.05

8022

39628

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2977

11381

1.71

144.73

3.8

24.82

24.79

mmol/l

0.25

2804

10474

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

29882

169243

1.24

141.60

3.0

2.7

—

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

26285

146881

1.24

140.45

4.5

3.6

0.79

0.45

estimate

0.75

6342

32439

(3052851) Hemolysis interference index of Serum or Plasma

2461

9033

1.77

137.81

3.1

3.2

1.81

2.34

index

2.46

1286

4558

(3005322) IgE [Units/volume] in Serum or Plasma

5568

24930

1.47

137.51

1.4

1.3

268.98

239.05

u/ml

0.53

5133

23332

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2654

9971

1.73

137.16

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

758

1719

2.84

136.27

1.9

1.4

2073518.23

1780596.11

iu/ml

0.24

(3034770) Mitochondria Ab [Titer] in Serum

2655

10010

1.73

135.48

1.2

692.88

968.79

titre

1.17

282

(3020961) Endomysium IgA Ab [Titer] in Serum

4242

18006

1.54

135.04

1.1

167.93

180.07

titre

0.11

542

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5761

26074

1.45

134.41

4.2

3.9

1.23

mmol/l

1.24

4921

22602

(3004716) Salmonella sp identified in Stool by Organism specific culture

4304

18348

1.54

134.35

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

2283

8274

1.79

133.31

3.5

3.3

62.97

62.40

0.55

2160

8023

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

57002

348853

1.35

132.75

5.4

4.8

4.64

4.66

mmol/l

6.91

53878

329937

(3016650) Hepatitis A virus Ab [Presence] in Serum

1809

6116

1.92

131.17

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

54217

329625

1.31

129.85

4.5

4.1

1.42

1.27

mmol/l

322.70

50442

308066

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10203

81984

0.76

127.88

4.1

4.3

21.40

22.02

3.40

4166

38156

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4595

20122

1.50

126.15

8.0

6.7

24.72

24.48

mmol/l

3.75

4449

19231

(3045414) Leukocytes [Presence] in Urine

7050

33462

1.39

125.66

2.1

2.0

0.02

0.03

estimate

0.22

1487

7005

(3014051) Protein [Presence] in Urine by Test strip

19469

106169

1.25

125.39

3.2

2.8

0.13

0.06

1.05

290

2178

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

56659

346957

1.34

125.05

5.3

4.7

1.40

1.46

mmol/l

238.78

53272

326552

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7377

61893

0.73

124.52

2.9

3.1

0.65

0.77

ug/l

14.82

4872

38058

(3025159) Blasts/Leukocytes in Blood

6518

30600

1.40

123.74

4.9

4.7

0.08

0.32

6.66

1631

7709

(3002179) Metamyelocytes/Leukocytes in Blood

6422

30088

1.41

123.33

4.3

0.61

0.72

2.83

1929

8839

(3017181) Myelocytes/Leukocytes in Blood

6699

31629

1.40

122.98

4.6

4.5

0.85

0.96

2.41

1994

9292

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1824

6326

1.87

122.42

1.4

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

996

2738

2.35

122.33

1.9

2.4

19.51

19.52

nmol/l

0.00

930

2612

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1823

6325

1.87

122.20

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5443

47815

0.70

121.94

1.8

1.9

3.54

3.50

ratio

1.42

3970

36294

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1400

4435

2.04

121.81

2.0

1.8

4317.65

3597.26

titre

0.22

175

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5673

26126

1.43

119.79

2.5

2.3

6.67

7.50

ug/l

1.58

4821

23050

(3007461) Platelets [#/volume] in Blood

62462

389519

1.57

118.62

31.5

21.8

260.98

252.71

e9/l

181.28

61543

381888

(3028626) Oxygen [Partial pressure] in Capillary blood

2226

8329

1.74

116.41

3.2

8.49

8.37

kpa

2.53

2178

8120

(1616796) Gas panel - Central venous blood

2024

7379

1.78

115.69

3.9

3.7

—

(3035941) MCH [Entitic mass]

62464

389693

1.56

115.54

31.3

21.6

30.23

30.26

2.65

62005

386035

(3024731) MCV [Entitic mean volume] in Red Blood Cells

62464

389694

1.56

115.52

31.4

21.7

90.77

90.76

0.38

62003

386029

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

62465

389719

1.56

115.18

32.1

22.1

40.51

41.14

7.33

61997

385894

(3026361) Erythrocytes [#/volume] in Blood

62464

389744

1.56

114.55

31.4

21.7

4.50

4.52

e12/l

26.26

61390

380950

(3010813) Leukocytes [#/volume] in Blood

62471

389807

1.56

114.37

31.5

21.8

6.92

6.68

e9/l

110.08

61423

380981

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2410

9278

1.69

113.71

2.2

1.8

193.02

203.81

pmol/l

4.34

2264

8889

(3018405) Lactate [Moles/volume] in Arterial blood

2580

10127

1.66

113.14

4.6

4.0

1.40

1.39

mmol/l

0.23

2549

9927

(3021440) Promyelocytes/Leukocytes in Blood

6389

30322

1.39

113.09

4.7

4.5

0.10

0.12

1.10

1684

8029

(3000963) Hemoglobin [Mass/volume] in Blood

62466

389845

1.55

112.90

31.7

21.9

135.05

136.03

g/l

55.03

62012

386267

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2485

9677

1.67

112.31

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1744

6147

1.84

111.22

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

6156

29156

1.39

110.13

2.5

2.7

72.54

69.44

e9/l

7.56

4367

21432

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3066

12648

1.58

109.91

2.1

1.8

39.10

41.17

nmol/l

3.83

2995

12420

(3022145) Colonoscopy Study observation

8282

41114

1.33

109.57

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1784

6366

1.82

109.37

1.6

1.5

0.37

0.41

nmol/l

0.74

1375

4956

(3035637) Corticotropin [Mass/volume] in Plasma

1359

4437

1.98

108.83

1.6

27.52

34.25

ng/l

2.47

1352

4429

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

543

1158

3.02

108.59

1.4

548.36

688.17

mu/l

0.65

509

1112

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

548

1177

3.00

108.30

1.4

73.63

72.84

0.58

514

1131

(3010421) pH of Blood

2600

10348

1.63

107.94

4.2

3.4

7.41

4.17

2549

10210

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6560

31539

1.37

106.86

2.8

2.2

12.36

13.16

nmol/l

11.64

5834

29006

(3020630) Protein [Mass/volume] in Serum or Plasma

5797

27325

1.39

106.48

2.3

2.7

66.57

66.45

g/l

0.59

5295

25178

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

190

167

7.30

105.37

1.1

1.3

50.70

45.62

mg/l

0.56

(3023420) DNA double strand Ab [Units/volume] in Serum

3567

15368

1.51

105.17

1.9

1.8

7.08

7.79

iu/ml

0.49

807

3610

(3026493) Urate [Moles/volume] in Serum or Plasma

17083

93215

1.23

104.91

2.6

2.7

331.71

339.75

umol/l

19.99

14917

83544

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3266

13815

1.54

104.78

1.6

1.7

15.97

15.86

u/ml

0.02

593

3672

(3008898) HLA-B27 [Presence]

3182

13403

1.55

104.02

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1135

3556

2.06

101.67

1.1

84.40

69.51

au/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3136

13288

1.54

99.71

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2720

11158

1.58

99.65

1.8

0.24

0.23

g/l

0.86

2588

10674

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3704

16263

1.49

99.53

4.5

3.9

50.91

47.65

12.03

3640

16060

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2781

11473

1.58

99.46

1.8

1.21

1.18

g/l

4.71

2656

11015

(3027315) Oxygen [Partial pressure] in Blood

1835

6815

1.74

98.33

4.6

3.8

8.82

8.70

kpa

2.05

1782

6666

(3012501) Base excess in Blood by calculation

1826

6772

1.75

98.33

4.5

3.7

2.43

2.49

mmol/l

0.42

1277

4512

(3013290) Carbon dioxide [Partial pressure] in Blood

1826

6774

1.75

98.23

4.5

3.7

5.08

4.98

kpa

6.38

1773

6626

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

103

19.42

97.12

1.8

1.1

240.21

172.63

nmol/l

0.60

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1053

3263

2.08

97.08

1.6

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

808

2250

2.31

96.47

3.1

30.30

24.25

mu/l

3.61

757

2125

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2826

11795

1.56

96.04

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

247

321

4.94

95.79

1.2

—

(3021901) Oxygen saturation in Capillary blood

1814

6767

1.74

95.69

3.0

90.90

90.40

2.81

1769

6580

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

4047

35955

0.70

94.77

1.6

3.48

mmol/l

0.04

2653

24264

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1463

16148

0.57

93.32

1.1

0.63

ratio

0.10

176

1844

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1298

4402

1.91

93.12

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13588

102321

0.81

92.04

4.7

5.2

2.17

2.90

ug/l

4.26

12154

93527

(3043409) Potassium [Moles/volume] in Arterial blood

2154

8507

1.64

91.98

4.9

4.4

3.83

3.88

mmol/l

5.05

2146

8430

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

709

1905

2.40

91.61

1.0

33.71

43.07

ng/l

5.94

514

1383

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

704

1895

2.39

90.62

1.0

249.87

361.55

ng/l

6.35

524

1396

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

706

1903

2.39

90.60

1.0

832.25

734.96

ng/l

5.23

512

1345

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1589

17025

0.59

90.37

1.1

1.52

1.51

g/l

0.95

1584

17012

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4239

19472

1.42

89.58

10.9

10.0

16.13

16.14

0.06

4120

18775

(3036180) Methadone [Presence] in Urine

24.52

89.41

3.3

2.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

937

2895

2.09

87.07

1.2

36.75

45.75

mg/l

5.88

796

2452

(3017509) Phencyclidine [Presence] in Urine

242

338

4.60

86.74

2.3

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

1849

7124

1.68

86.73

3.5

3.1

62.29

62.76

0.39

1841

7101

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1095

3589

1.97

86.73

1.3

1.2

32.33

34.50

nmol/l

0.12

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2632

11089

1.54

85.62

1.3

37.68

38.42

u/ml

0.04

115

613

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

911

2809

2.09

85.11

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7844

39903

1.29

84.98

3.9

4.6

230.13

243.11

u/l

12.86

7395

38037

(3029634) Reagin Ab [Titer] in Serum by VDRL

1484

5419

1.77

84.20

2.5

2.2

7.98

8.10

titre

0.02

147

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6692

33389

1.31

83.60

4.2

3.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2447

10199

1.56

83.48

2.0

7.57

16.70

iu/l

0.79

972

4248

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1695

17525

0.61

83.23

1.2

1.1

0.89

g/l

0.04

1686

17473

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

900

2804

2.07

81.85

1.1

239.51

278.98

mg/l

4.16

793

2502

(3004588) Protein electrophoresis panel - Serum or Plasma

4597

21751

1.38

81.44

2.2

2.5

—

2.00

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3400

15282

1.45

80.59

1.9

2.1

40.12

39.81

u/l

0.37

3055

13756

(3021367) Citalopram [Moles/volume] in Serum or Plasma

19.94

79.94

1.4

1.2

139.02

118.79

nmol/l

0.41

(3036489) Thrombin time

3116

13812

1.47

79.36

2.1

20.67

21.00

2.02

2742

12128

(40767503) Oxygen content in Capillary blood by calculation

1775

6929

1.66

79.20

2.9

2.6

16.81

16.65

1.32

1731

6782

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

856

2655

2.08

78.78

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

734

2162

2.19

76.94

1.2

1.3

0.63

0.66

ratio

0.45

429

1235

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

18.34

76.67

1.8

1.2

246.88

281.28

nmol/l

0.12

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2026

8250

1.59

76.31

1.2

1.3

42.94

45.30

u/ml

0.22

160

771

(3028271) Lactate [Moles/volume] in Capillary blood

1367

5019

1.76

76.14

2.2

1.8

1.72

1.74

mmol/l

0.17

1331

4887

(3027273) Bicarbonate [Moles/volume] in Venous blood

3249

14681

1.44

74.72

3.9

3.4

25.34

25.26

mmol/l

0.59

3118

14214

(3030981) Hyaline casts [#/volume] in Urine by Automated count

5671

28158

1.32

72.71

2.6

2.4

0.38

0.39

e6/l

0.16

5418

26858

(3026389) Candida sp identified in Specimen by Organism specific culture

1408

5312

1.71

71.29

1.4

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

715

2165

2.13

70.04

1.4

1.3

5.11

5.26

umol/l

0.43

631

1932

(3016038) Potassium [Moles/volume] in Urine

691

2076

2.14

69.04

1.3

31.20

34.69

mmol/l

3.47

592

1837

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2178

9229

1.53

68.84

2.2

2.4

0.00

g/l

0.13

1901

8107

(43055514) Macroprolactin [Presence] in Serum or Plasma

390

900

2.78

68.22

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2841

12752

1.45

67.57

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2397

10438

1.49

66.53

1.3

6.66

6.71

u/ml

0.01

167

1015

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2573

11366

1.47

66.48

2.2

2.5

0.63

0.77

g/l

1.28

2234

9802

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2392

10420

1.49

66.27

1.3

6.91

8.99

u/ml

0.74

266

1535

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

10.15

66.21

2.0

2.1

251.61

235.25

ug/l

0.26

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2244

9686

1.50

65.00

2.1

2.3

0.02

g/l

0.02

2026

8729

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3219

14902

1.40

64.46

1.5

1.6

9.06

14.87

iu/ml

1.70

433

(3045424) Erythrocytes [Presence] in Urine

3650

17269

1.37

64.17

2.2

2.1

0.02

0.12

estimate

0.94

1206

5586

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1843

7645

1.56

64.06

1.3

262.72

254.42

u/ml

0.57

1180

4843

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

836

2781

1.94

63.55

1.1

639.63

288.78

mg/l

0.50

761

2553

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2032

8632

1.52

63.45

2.2

2.4

0.00

g/l

-0.00

1894

8092

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1963

8277

1.53

63.42

2.3

2.2

132.28

130.69

g/l

2.01

1528

6423

(3013005) Retinol [Moles/volume] in Serum or Plasma

551

1566

2.26

62.97

1.9

1.95

1.96

umol/l

0.13

499

1435

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

822

2730

1.94

62.79

1.3

2.02

2.11

mmol/l

1.13

760

2540

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1938

8173

1.53

62.56

1.3

50.39

41.88

u/ml

0.19

135

(3024980) IgG subclass 4 [Mass/volume] in Serum

1535

6163

1.61

61.24

1.5

1.6

0.67

0.78

g/l

3.60

1203

4798

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1301

5012

1.67

61.02

1.3

0.14

0.28

nmol/l

3.87

101

295

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3292

15452

1.38

60.67

1.8

1.52

g/l

0.01

2860

13297

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2814

12861

1.42

60.55

2.1

1.9

1.99

2.33

ug/l

0.84

2508

11394

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

434

1128

2.47

60.36

1.4

13.32

15.21

pmol/l

8.86

351

967

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2025

8704

1.50

59.81

1.2

1.3

2.91

5.31

u/ml

1.17

607

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

749

2450

1.97

59.78

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2950

13642

1.40

59.35

1.3

219.16

223.70

miu/ml

0.25

1143

6611

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

934

3298

1.82

59.24

1.4

1.3

1.50

1.44

nmol/l

0.92

854

2977

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1172

4432

1.71

58.87

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1668

6898

1.56

58.74

2.8

2.1

0.92

0.86

nmol/l

2.42

1400

5890

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

739

2421

1.96

58.74

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2742

12549

1.42

58.52

2.1

2.4

2.88

2.89

g/l

0.26

2495

11425

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2078

9033

1.49

58.11

1.3

25.07

14.99

u/ml

0.43

106

(40761536) Microorganisms panel - Urine sediment

5656

28892

1.28

57.73

4.6

3.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

632

1969

2.06

57.63

1.1

3.28

6.30

nmol/l

1.12

105

370

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1273

4955

1.66

57.43

1.3

1.58

1.48

nmol/l

0.04

1228

4794

(3022806) Fractional oxyhemoglobin in Capillary blood

1047

3863

1.75

57.39

2.1

1.7

89.88

90.09

0.58

1028

3805

(3011648) Oxygen content in Venous blood

960

3461

1.79

56.92

2.3

2.5

11.05

11.03

0.04

954

3447

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1998

8653

1.49

56.89

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2421

10899

1.44

56.54

2.5

2.6

186.03

188.64

0.70

2304

10365

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

593

1820

2.10

56.24

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2047

8947

1.48

55.70

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2504

11378

1.42

55.58

2.1

2.3

9.78

10.19

g/l

5.10

2232

10149

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2853

13279

1.39

55.20

2.1

2.4

7.32

7.36

g/l

0.48

2606

12151

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2849

13261

1.39

55.11

2.1

2.4

4.24

4.22

g/l

0.85

2606

12148

(3037121) Protein [Mass/volume] in Urine

2522

11499

1.42

54.92

3.4

482.62

518.73

mg/l

0.13

1157

5414

(3012920) Ethanol [Mass/volume] in Serum or Plasma

15.52

54.49

1.5

1.1

2.08

2.02

g/l

0.11

(3039443) Prostate specific Ag panel - Serum or Plasma

499

6482

0.49

54.49

1.4

1.6

—

21.18

—

(3041096) Erythrocytes [Presence] in Urine by Automated

18657

107321

1.16

54.46

3.7

3.1

0.26

0.24

estimate

0.06

6310

31615

(3006922) Hepatitis E virus Ab [Presence] in Serum

828

2892

1.84

54.40

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1627

6808

1.54

54.40

1.8

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2840

13243

1.39

54.33

2.1

2.4

3.72

g/l

0.01

2601

12127

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1168

4512

1.67

54.25

6.8

6.1

11.40

11.58

mg/l

0.64

1084

4183

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1834

7888

1.50

53.99

1.4

20.04

21.32

u/ml

0.11

151

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

728

2451

1.91

53.51

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1843

7956

1.50

53.29

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2567

11804

1.41

53.27

2.3

94.89

93.56

2.02

2473

11345

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

499

1463

2.19

53.08

1.9

27.90

28.92

umol/l

1.34

470

1369

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

610

1948

2.01

52.12

1.5

5.84

6.19

u/l

0.26

502

1687

(3020911) Cortisol [Moles/time] in 24 hour Urine

432

1203

2.31

51.84

1.4

164.09

189.89

nmol/24h

0.14

432

1203

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

617

1985

2.00

51.66

1.1

1.08

1.13

u/l

0.49

224

835

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1105

4262

1.67

51.64

1.3

0.18

0.27

nmol/l

0.81

811

3372

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2478

11391

1.41

51.50

2.8

2.6

3.59

3.60

g/l

0.11

2374

10920

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2236

10110

1.43

50.96

1.1

3.81

5.52

eliau/ml

1.37

233

1403

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

535

1649

2.09

50.25

1.2

1.3

59.68

64.99

0.46

210

(3017950) Salicylates [Moles/volume] in Serum or Plasma

10.34

50.09

1.9

1.2

1532.00

647.40

umol/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1128

4412

1.65

49.98

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

543

1687

2.07

49.96

1.6

13.08

5.29

nmol/l

0.36

438

1410

(3025130) Human papilloma virus identified in Specimen

1464

6103

1.55

49.78

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1697

7305

1.50

49.75

1.5

142.81

149.70

au/ml

1.40

467

2077

(3003129) Base excess in Capillary blood by calculation

1003

3823

1.69

49.01

2.2

0.77

0.44

mmol/l

1.97

957

3652

(3040151) Glucose [Moles/volume] in Capillary blood

987

3749

1.70

48.85

8.2

7.1

7.50

7.26

mmol/l

0.70

813

3101

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1805

7903

1.47

48.68

1.5

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

388

1062

2.35

48.43

3.0

29.25

28.38

umol/l

0.53

275

828

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7453

39992

1.22

48.34

5.0

4.7

30.71

32.47

35.25

5441

27419

(3011985) Renin [Units/volume] in Plasma

1272

5170

1.59

48.27

1.6

66.25

62.52

mu/l

0.20

1139

4687

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2172

9872

1.42

48.09

1.5

15.83

12.53

iu/ml

0.34

225

(3045716) Anion gap in Serum or Plasma by calculation

928

3484

1.71

47.92

3.4

3.0

10.52

10.75

mmol/l

0.87

911

3446

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1248

5060

1.59

47.86

1.1

1.50

g/l

0.06

1138

4654

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1097

4318

1.64

47.44

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

525

1645

2.05

47.27

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

461

1378

2.15

46.84

2.9

2.4

53.50

51.37

umol/l

0.70

393

1215

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1094

4325

1.63

46.51

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

402

1139

2.27

46.44

1.9

2.6

0.98

1.10

ug/l

0.52

373

1085

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1051

4115

1.65

46.41

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1048

4104

1.64

46.25

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1051

4122

1.64

46.11

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2750

13111

1.36

45.77

2.2

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1376

5786

1.53

45.02

1.1

757.36

2515.31

iu/ml

0.42

295

1203

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

699

2465

1.82

44.65

1.1

—

0.25

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

5347

27956

1.24

44.16

2.8

2.7

71.64

67.79

ml/min/173m2

8.91

2347

11528

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1171

4769

1.58

44.10

1.4

349.13

363.92

pmol/l

0.18

1010

4117

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2121

9756

1.40

43.88

1.9

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

347

945

2.36

43.86

1.4

1.2

130.03

131.34

nmol/l

0.04

237

705

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3074

15018

1.33

43.42

5.8

4.7

1.83

1.62

14.78

2925

14250

(3047181) Lactate [Moles/volume] in Blood

2177

10084

1.39

43.23

6.5

5.4

1.36

1.30

mmol/l

1.78

1940

8938

(3020717) Zinc [Moles/volume] in Serum or Plasma

591

1998

1.90

43.03

1.7

1.5

19.22

24.46

umol/l

4.79

543

1864

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2526

12006

1.36

42.85

2.0

1.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1232

5123

1.55

42.40

1.2

19.54

17.10

u/ml

0.14

216

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1500

6534

1.48

41.52

1.5

1.4

—

(4024509) Urine culture

3158

15602

1.31

41.16

2.0

1.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

469

1487

2.03

41.00

2.2

2.1

17.39

24.90

umol/l

0.96

140

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2094

9730

1.39

40.82

2.0

2.1

11.52

11.32

mg/l

0.46

1961

9151

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

508

1666

1.96

40.45

1.8

1.5

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

13.34

40.41

3.3

2.9

2.54

ug/l

0.01

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2170

10181

1.38

39.90

1.2

1.1

—

(4062490) Immunoglobulin typing, IgG

950

3770

1.62

39.85

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1110

4580

1.56

39.56

1.2

1.3

52.92

53.61

u/ml

0.03

275

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

239

571

2.69

39.49

1.3

1.8

0.92

1.24

nmol/l

1.08

(3017315) Amylase [Enzymatic activity/volume] in Urine

522

1744

1.92

39.41

1.3

1.2

271.58

332.43

u/l

0.77

482

1632

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

353

1025

2.21

38.61

1.2

22.67

20.62

0.14

188

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2108

9907

1.37

38.35

1.2

4.81

3.89

1.71

206

1609

(3024139) IgG subclass 3 [Mass/volume] in Serum

956

3840

1.60

38.20

1.4

0.38

0.41

g/l

1.64

693

2765

(3028192) IgG subclass 2 [Mass/volume] in Serum

956

3842

1.60

38.12

1.4

2.90

2.97

g/l

0.54

690

2765

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1499

6641

1.46

38.09

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

956

3845

1.60

38.00

1.4

6.46

6.79

g/l

1.87

690

2768

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

49482

306592

1.13

37.91

26.7

18.0

332.47

332.74

g/l

8.61

49233

304835

(3001186) Copper [Moles/volume] in Serum or Plasma

331

943

2.25

37.88

1.4

1.3

16.77

16.50

umol/l

0.39

285

815

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1338

5803

1.49

37.87

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

439

1405

2.01

37.47

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1706

7790

1.41

36.80

5.8

5.9

4104.59

1014.78

iu/ml

0.49

204

1160

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2323

11172

1.34

36.46

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1348

5911

1.47

36.13

1.3

3.68

4.00

u/ml

0.46

638

2809

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

356

1070

2.14

35.84

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

545

1914

1.83

35.40

1.6

1.35

1.26

nmol/l

0.99

397

1482

(3034274) Bile acid [Moles/volume] in Serum --fasting

1316

5777

1.47

35.09

2.0

2.2

6.84

6.50

umol/l

0.21

967

4240

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

661

2468

1.72

34.96

1.2

1.1

1.04

2.89

0.85

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1308

5753

1.46

34.54

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1186

5132

1.49

33.99

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1263

5535

1.47

33.98

1.1

120.20

117.19

2.55

1155

5035

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1001

4203

1.53

33.08

1.6

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

671

2556

1.69

33.04

1.3

1.4

11.91

12.42

umol/l

1.03

622

2431

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.73

32.99

1.2

1.1

—

mmol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2513

12404

1.31

32.90

1.6

7.09

5.70

iu/ml

0.08

449

2244

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1348

6022

1.44

32.83

2.8

2.9

1532.74

6342.36

u/ml

1.21

345

(44813793) Dust mix specific IgE antibody measurement

691

2659

1.67

32.77

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1361

6095

1.44

32.72

1.2

1.3

2.79

3.84

u/ml

1.74

506

2353

(40768800) Prostate Pathology biopsy report

593

6303

0.60

32.47

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4712

25097

1.22

32.20

3.0

2.9

149.26

196.07

ng/l

11.30

4220

22928

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

597

2230

1.72

31.59

2.3

2.1

99.14

98.08

0.28

564

2087

(3013247) Albumin in CSF/Albumin in Serum or Plasma

270

768

2.26

31.13

1.1

6.27

7.47

mg/g

1.72

261

733

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

742

2949

1.62

31.06

1.2

109.17

112.34

pmol/l

0.92

742

2949

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

199

491

2.60

31.05

1.5

1.3

63.68

263.70

ng/l

0.66

110

332

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

935

3925

1.53

30.97

2.2

2.0

20.92

26.59

mg/l

3.54

351

1455

(40759836) Histone Ab [Presence] in Serum by Immunoblot

772

3101

1.60

30.95

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

859

3540

1.56

30.89

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

1039

4464

1.50

30.87

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

1038

4461

1.50

30.80

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

1038

4462

1.50

30.76

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2262

11108

1.31

30.73

3.8

3.6

1.48

1.49

mg/l

0.01

2091

10222

(44790047) Parainfluenza type 1 nucleic acid detection

1038

4467

1.50

30.60

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

784

3172

1.59

30.51

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1395

6367

1.41

30.23

1.8

2.0

5.06

5.20

mmol/24h

0.63

1249

5746

(3018333) Ribosomal P Ab [Presence] in Serum

722

2871

1.62

30.18

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

341

1084

2.02

29.78

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

614

2350

1.68

29.77

2.8

2.5

0.76

0.68

e9/l

2.45

591

2257

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

738

2961

1.60

29.75

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

867

3620

1.54

29.45

1.2

57.53

63.94

u/l

2.70

764

3194

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

756

3061

1.59

29.35

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

568

2140

1.70

29.19

1.4

1.6

7.31

8.43

ug/l

0.78

521

1951

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

734

2955

1.60

29.19

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

756

3067

1.58

29.12

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

724

2909

1.60

29.03

1.2

159.73

210.13

titre

0.89

111

456

(4195642) Thrombophilia screening test

1227

5517

1.43

28.91

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

721

2903

1.60

28.67

1.2

204.74

200.00

titre

0.02

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1880

9095

1.33

28.38

1.1

1.97

2.20

u/ml

0.46

1064

4775

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

399

1367

1.87

28.14

2.6

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2705

13755

1.27

28.10

6.3

4.9

0.87

0.88

0.26

2571

13013

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

493

1804

1.75

28.10

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1004

4369

1.48

28.07

1.6

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

252

731

2.21

27.82

1.7

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

833

3496

1.53

27.68

1.6

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

221

611

2.32

27.27

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

364

1235

1.89

26.48

1.3

1.2

109.72

110.61

0.23

328

1117

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

383

1323

1.86

26.38

1.3

1.2

0.31

0.30

g/l

1.76

311

1055

(40768443) Skin Pathology biopsy report

3099

16132

1.24

26.27

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1378

6447

1.38

25.86

1.2

1.3

77.39

138.00

titre

1.40

130

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1364

6386

1.37

25.50

1.3

315.56

289.45

titre

0.14

484

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

327

1085

1.93

25.43

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

244

726

2.16

25.39

1.7

1.4

0.20

0.33

mmol/l

1.06

129

(3003888) Timothy IgE Ab [Units/volume] in Serum

1645

7936

1.34

25.34

1.1

5.16

5.50

u/ml

0.37

909

4209

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

959

4224

1.46

25.27

1.1

97.22

96.85

0.15

899

3972

(3044242) Glucose [Moles/volume] in Arterial blood

455

1684

1.73

25.01

2.4

1.9

8.20

8.09

mmol/l

0.22

455

1684

(3000475) Leukocytes [#/volume] in Synovial fluid

1757

8575

1.32

24.98

1.6

1.7

11141.41

13623.62

e6/l

1.83

1209

6167

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

529

2042

1.66

24.95

2.0

1.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

453

1681

1.73

24.68

1.2

1.3

159.36

160.68

mmol/24h

0.11

453

1681

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

308

1012

1.95

24.66

4.4

2.8

5.03

4.89

kpa

1.28

308

1012

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

308

1012

1.95

24.66

4.4

2.8

10.30

10.54

kpa

0.63

308

1012

(3035715) Granulocytes [#/volume] in Blood

1411

6689

1.36

24.41

3.4

3.3

4.15

4.06

e9/l

0.77

1405

6678

(4268621) Lupus anticoagulant assay

958

4250

1.45

24.34

2.3

—

(3022621) pH of Urine by Test strip

5267

29065

1.17

24.03

2.8

2.5

6.12

6.09

2.14

3474

18840

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1571

7589

1.33

24.00

1.1

1.08

1.06

u/ml

0.03

736

3312

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

598

2407

1.60

23.92

2.6

2.4

531.04

528.77

e6/l

0.03

474

1929

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2181

11028

1.27

23.74

2.9

3.5

36.26

43.19

mg/l

2.01

1832

9396

(3004616) Nuclear Ab [Presence] in Serum

1013

4564

1.43

23.70

1.4

1.3

—

(21494815) CD4 cells/Lymphocytes in Specimen

737

3118

1.52

23.69

2.4

2.2

40.39

38.84

2.01

723

3065

(3034860) Kappa light chains.free [Mass/volume] in Serum

2181

11047

1.27

23.41

2.9

3.5

65.71

62.76

mg/l

0.05

1835

9409

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

418

1547

1.73

23.03

1.1

9.44

10.41

u/ml

0.21

274

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

517

2033

1.63

22.75

1.2

1.3

26.42

25.06

u/l

0.20

443

1713

(3023419) Bacteria identified in Sputum by Culture

931

4163

1.44

22.72

2.6

—

(3011412) CD3 cells [#/volume] in Blood

789

3419

1.48

22.64

2.6

2.3

1325.47

1188.59

e6/l

2.68

679

2998

(3035320) C reactive protein [Mass/volume] in Body fluid

649

2699

1.54

22.59

3.2

2.5

23.75

29.04

mg/l

3.02

449

1946

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1210

5670

1.37

22.55

1.4

1.5

15.75

13.41

u/ml

0.17

128

(3017569) Oxygen content in Arterial blood

445

1688

1.69

22.47

2.4

2.2

16.35

15.94

1.77

445

1688

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

527

2090

1.62

22.43

1.2

1.3

98.79

90.15

u/l

0.83

461

1791

(3011048) Pyruvate [Moles/volume] in Blood

167

3.41

22.20

1.4

85.58

73.86

umol/l

1.84

153

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1537

7494

1.32

22.05

1.5

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

605

2495

1.56

21.87

2.7

2.6

223.48

229.39

e6/l

0.30

500

2108

(4146454) Self-monitoring of blood glucose

770

3349

1.48

21.71

2.7

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

713

3053

1.50

21.70

4.0

3.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2098

10679

1.27

21.65

3.5

3.1

0.34

0.35

iu/ml

0.34

1126

5841

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

257

831

1.98

21.61

1.1

—

(3001556) Androgen free Index in Serum or Plasma

141

354

2.55

21.45

1.4

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

744

3222

1.48

21.44

1.7

1.8

—

(3014271) Vancomycin [Susceptibility]

368

1342

1.76

21.38

3.2

2.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

652

2754

1.52

21.18

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

652

2754

1.52

21.18

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

652

2754

1.52

21.18

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

549

2231

1.58

21.17

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

686

2931

1.50

21.12

2.9

2.7

—

(3051651) Icteric interference index of Serum or Plasma

471

1846

1.64

21.05

4.0

3.8

0.75

0.90

index

2.47

459

1802

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1496

7320

1.32

20.95

2.4

119.45

106.33

ug/min

0.42

870

4405

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

139

351

2.54

20.92

2.2

3.6

41.08

41.93

umol/l

0.17

120

299

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

258

852

1.94

20.47

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

129

324

2.55

19.66

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

191

573

2.14

19.62

1.5

1.6

0.28

0.22

nmol/l

0.87

142

423

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

667

2881

1.49

19.53

1.3

2.16

1.91

u/ml

0.22

405

1646

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

834

3762

1.42

19.49

1.2

49.52

44.83

u/ml

0.17

186

(3039000) Anion gap in Blood by calculation

1396

6850

1.31

19.19

8.1

6.5

11.35

11.27

mmol/l

0.32

1280

6178

(3018572) Chloride [Moles/volume] in Blood

1396

6851

1.31

19.17

8.1

6.5

104.76

105.12

mmol/l

1.80

1280

6181

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

457

1824

1.61

19.06

1.6

2.0

139.16

148.12

1.66

432

1733

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1519

7547

1.30

19.04

1.1

1.77

1.95

u/ml

0.37

861

3701

(3010015) Selenium [Moles/volume] in Serum or Plasma

134

349

2.46

18.99

2.0

1.9

1.30

1.35

umol/l

0.78

101

251

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

336

1239

1.74

18.87

3.1

2.8

0.60

0.61

mmol/l

0.80

336

1239

(37208534) Antinuclear antibody arbitrary concentration in serum

327

1199

1.75

18.73

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

595

2533

1.51

18.71

1.6

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

730

3239

1.45

18.67

3.7

3.4

15.18

14.09

index

0.82

460

1803

(3028717) Thiamine [Mass/volume] in Blood

157

445

2.26

18.51

1.2

64.48

63.01

ug/l

0.38

157

445

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1912

9815

1.25

18.40

2.9

3.4

2.76

5.49

ratio

1.26

1022

5652

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

494

2029

1.56

18.29

3.0

2.7

41.42

39.07

1.90

260

1114

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

228

754

1.94

18.09

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

186

573

2.08

17.91

1.5

5.51

5.71

nmol/l

0.26

176

551

(3004809) Band form neutrophils/Leukocytes in Blood

1158

5596

1.33

17.77

3.0

3.4

1.31

1.57

2.08

1044

5019

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

165

487

2.17

17.70

1.1

1.0

83.44

82.20

ug/l

0.12

134

376

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1030

4897

1.35

17.63

2.7

2.9

142.03

739.88

u/ml

1.70

1017

4845

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

327

1221

1.72

17.62

1.1

94.31

89.82

1.67

143

590

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

559

2380

1.51

17.61

2.8

3.6

110.07

149.42

nmol/l

1.69

543

2346

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

882

4092

1.38

17.59

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

420

1678

1.61

17.50

1.1

3.43

3.94

iu/ml

0.51

137

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

171

517

2.12

17.30

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

169

3.07

17.27

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

342

1304

1.68

17.10

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

453

1859

1.56

16.88

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

499

2093

1.53

16.87

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

106

261

2.60

16.87

1.5

1.3

14.75

12.43

pmol/l

0.35

212

(3026250) Tacrolimus [Mass/volume] in Blood

418

1687

1.59

16.73

44.9

42.4

7.31

7.28

ug/l

0.13

385

1532

(1175426) CD3 cells/Lymphocytes in Blood

630

2778

1.46

16.71

2.2

2.0

75.08

72.73

4.08

604

2681

(3000060) B lymphocytes [#/volume] in Blood

297

1099

1.73

16.56

2.3

2.0

0.16

0.78

e9/l

1.43

142

514

(3017354) Segmented neutrophils/Leukocytes in Blood

780

3586

1.40

16.46

2.8

3.5

57.63

57.27

0.19

677

3090

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

490

2063

1.52

16.31

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

606

2669

1.46

16.19

2.2

2.0

13.25

15.12

4.83

590

2602

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

187

602

1.99

16.08

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

699

3166

1.42

16.07

1.2

66.73

68.81

u/ml

0.05

118

(3036603) Volume of Urine

602

2653

1.46

16.04

1.6

1.7

2233.40

1960.47

4.45

592

2593

(3006245) CD3-CD19+ cells/cells in Blood

368

1458

1.62

15.92

2.4

2.2

8.53

10.25

2.04

346

1360

(3021788) Differential panel - Synovial fluid

1320

6598

1.29

15.88

1.6

1.00

0.96

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

338

1313

1.65

15.80

1.6

2.1

153.90

169.06

2.03

322

1244

(3034988) Calcium [Moles/volume] in Capillary blood

170

533

2.04

15.71

1.8

2.3

1.18

mmol/l

0.00

157

510

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

326

1258

1.66

15.64

1.2

113.83

107.16

2.07

304

1138

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

422

2.17

15.42

2.3

2.4

0.89

1.34

mmol/l

1.98

287

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

314

1205

1.67

15.39

1.1

96.19

90.15

1.58

140

589

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

714

3274

1.40

15.34

4.0

5.5

57.70

112.87

u/ml

2.44

214

1153

(3002619) Bacteria identified in Specimen by Culture

246

883

1.79

15.26

1.2

—

(4034850) Laboratory test

1981

10424

1.22

15.24

11.7

9.2

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

9.20

15.16

1.3

4.4

80.64

54.00

nmol/l

0.99

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1331

6703

1.28

15.11

1.1

23.58

14.77

au/ml

2.26

258

1948

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

629

2831

1.43

15.02

1.2

82.68

80.10

0.43

200

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

387

1575

1.58

15.02

1.1

0.08

0.45

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1134

5603

1.30

14.93

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

351

1399

1.61

14.86

2.3

2.0

29.11

29.51

0.22

335

1335

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

602

2697

1.43

14.76

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

140

418

2.15

14.70

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

367

1485

1.59

14.61

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

367

1486

1.58

14.57

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

179

589

1.95

14.53

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

363

1474

1.58

14.26

1.1

573.18

386.06

ng/l

0.16

413

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

255

2.46

14.06

1.2

1.3

23.39

15.25

nmol/l

0.53

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

340

1364

1.60

14.05

1.8

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

185

624

1.90

14.00

1.1

0.81

2.99

umol/24h

0.48

319

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

148

464

2.04

13.75

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

168

553

1.95

13.66

1.9

2.3

1.19

mmol/l

0.08

156

529

(3001964) Herpes simplex virus Ag [Presence] in Specimen

253

950

1.71

13.51

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

466

2028

1.47

13.35

1.6

7.71

6.75

u/l

0.61

361

1621

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3437

19196

1.15

13.30

2.9

3.5

55.38

51.43

u/ml

0.16

3309

18582

(3038026) Centromere Ab [Units/volume] in Serum

598

2730

1.41

13.26

1.2

56.29

52.25

u/ml

0.11

177

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1146

5769

1.28

13.13

1.2

1.3

28.60

32.77

u/l

0.70

1010

5035

(3033942) Copper [Moles/time] in 24 hour Urine

141

2.95

13.11

1.2

0.91

0.75

umol/24h

0.12

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

502

2227

1.45

13.04

2.6

806.42

1025.47

u/ml

1.36

497

2199

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

885

4311

1.32

13.00

2.0

2.3

32.34

32.51

0.51

880

4281

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1757

9306

1.21

12.73

1.4

1.5

—

(3020491) Glucose [Moles/volume] in Blood

552

2510

1.41

12.55

1.9

1.7

6.95

6.64

mmol/l

1.28

415

1863

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

315

1279

1.58

12.45

2.2

2.1

62.05

61.19

ug/l

0.06

309

1253

(3022493) Free Hemoglobin [Mass/volume] in Plasma

369

1554

1.52

12.42

4.2

4.6

614.14

2591.00

mg/l

1.92

266

1111

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1938

1.47

12.40

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

313

2.21

12.28

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

209

766

1.75

12.21

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

310

1261

1.58

12.18

1.2

0.67

0.46

g/l

0.17

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1070

5396

1.27

12.12

1.1

2.03

2.86

2.87

125

1010

(3045683) HLA typing for celiac disease panel - Blood or Tissue

511

2309

1.42

12.06

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

842

4118

1.31

12.06

1.2

1.1

2.25

1.99

iu/ml

0.13

(3012494) Peanut IgE Ab [Units/volume] in Serum

262

1026

1.64

12.02

1.1

1.67

15.87

u/ml

0.87

159

592

(3037756) Immunofixation for Serum or Plasma

1299

6711

1.24

11.98

1.5

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

305

1246

1.57

11.78

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

156

528

1.89

11.78

2.4

2.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

451

2004

1.44

11.68

1.2

1.3

57.00

78.80

titre

0.66

150

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

461

2058

1.44

11.65

1.2

1.3

699.47

474.79

titre

0.26

144

(3000012) Reticulocyte production index

916

4569

1.29

11.36

2.0

2.2

0.91

0.02

614

3089

(3028433) Virus identified in Specimen by Culture

262

1042

1.61

11.34

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

362

1552

1.50

11.26

1.0

1.1

99.40

96.68

0.90

283

1237

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

687

5792

0.76

11.22

3.3

2.5

13.21

13.14

1.12

679

5724

(40768441) Liver Pathology biopsy report

562

2618

1.38

11.16

1.5

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

209

787

1.70

11.16

1.1

3.73

1.42

u/ml

0.36

179

683

(3018851) Theophylline [Moles/volume] in Serum or Plasma

232

2.35

11.12

1.7

1.8

48.67

46.94

umol/l

0.18

232

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

186

2.51

11.04

1.6

1.8

200.40

183.78

ug/g

0.33

163

(3010503) CD19 cells [#/volume] in Blood

462

2088

1.42

10.95

2.8

2.5

238.33

309.50

e6/l

0.39

447

2035

(3003694) ABO and Rh group [Type] in Blood

18143

110837

1.07

10.94

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

675

3250

1.33

10.85

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

208

789

1.69

10.83

1.1

1.2

93.24

86.97

0.68

234

(3051339) Copper [Moles/volume] in Blood

154

2.66

10.82

1.4

1.2

16.54

16.36

umol/l

0.10

131

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

756

3701

1.31

10.82

1.4

9.29

8.16

mmol/l

8.24

722

3540

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

250

996

1.61

10.78

3.2

3.1

1.89

1.84

ratio

0.23

223

920

(3002256) Pathology report gross observation

8048

47733

1.09

10.72

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

188

696

1.73

10.68

1.1

1.83

7.38

u/ml

1.99

130

437

(40760888) Immunoglobulin light chains.free panel - Serum

1385

7297

1.22

10.66

2.9

3.6

—

245.32

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

274

2.20

10.61

2.8

4.4

2.14

2.31

mg/l

0.42

235

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

295

2.15

10.60

1.6

2.07

1.54

mg/l

0.45

187

(3042631) Mycobacterium sp identified in Specimen

845

4211

1.29

10.59

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

404

1793

1.44

10.59

9.8

5.8

721.38

3753.53

u/ml

0.73

117

289

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

218

843

1.66

10.58

1.1

1.3

111.58

105.82

1.91

203

803

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

597

2840

1.35

10.42

1.1

8.05

7.93

iu/ml

0.04

125

824

(3042733) HLA Ab [Presence] in Serum

300

1258

1.53

10.40

4.9

5.1

—

(3024869) Neuronal Ab [Presence] in Serum

158

562

1.80

10.29

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

783

3880

1.30

10.27

3.1

3.5

5.24

8.58

nmol/l

0.91

757

3760

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

157

558

1.80

10.26

2.0

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

501

2327

1.38

10.18

1.1

1.2

1.06

ratio

0.09

416

1946

(3006270) Folate [Moles/volume] in Blood

542

2552

1.36

10.13

1.2

373.35

373.39

nmol/l

0.00

469

2175

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

238

955

1.60

10.01

1.6

1.7

9.46

9.27

ug/l

0.26

238

955

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

504

1.83

9.90

2.1

2.0

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.28

9.87

1.1

1.2

246.65

390.62

pmol/l

0.92

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

204

794

1.65

9.70

1.1

1.2

76.87

76.32

0.04

225

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

189

723

1.68

9.60

1.3

1.2

445.68

288.17

pmol/l

0.94

125

553

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

425

1942

1.40

9.55

1.2

1.1

82.02

83.02

u/l

0.08

370

1748

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

907

4622

1.26

9.54

2.5

31.90

26.55

iu/ml

0.53

436

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

128

437

1.88

9.52

1.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

359

1593

1.44

9.48

1.5

1.4

0.52

e9/l

0.24

359

1593

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

309

2.05

9.48

1.0

1.1

0.06

0.05

u/ml

0.19

309

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

163

601

1.74

9.46

2.9

2.7

36.99

45.33

mg/l

0.38

145

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

864

1.61

9.45

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

209

825

1.62

9.42

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

504

2376

1.36

9.39

1.3

1.6

24.94

24.86

u/ml

0.01

432

(3027974) Hepatitis B virus e Ag [Presence] in Serum

222

2.25

9.37

1.5

1.6

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

144

2.58

9.30

1.0

0.20

0.12

u/ml

0.35

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

1.87

1.86

mg/l

0.01

193

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

1.22

1.36

mg/l

0.11

174

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

2.26

2.58

mg/l

0.19

210

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

0.50

0.89

mg/l

0.98

195

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

3.92

4.01

mg/l

0.04

185

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

1.78

2.28

mg/l

0.45

202

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

290

2.08

9.29

1.6

1.99

2.13

mg/l

0.07

211

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

291

2.07

9.21

1.6

1.71

1.79

mg/l

0.08

209

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

291

2.07

9.21

1.6

1.94

1.68

mg/l

0.18

174

(3010370) Gastrin [Moles/volume] in Serum or Plasma

152

554

1.76

9.19

1.8

1.9

66.79

49.57

pmol/l

0.25

126

472

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

419

1933

1.39

8.94

1.2

1.1

22.75

23.29

u/l

0.06

369

1735

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1060

5540

1.23

8.92

1.1

2.38

2.90

eliau/ml

1.33

382

2814

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1204

6384

1.21

8.78

1.1

6.28

4.52

u/ml

1.41

591

2848

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1269

6763

1.20

8.78

1.1

5.08

3.79

u/ml

1.09

669

3364

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1188

6300

1.21

8.66

1.3

1.4

3.01

3.64

ug/l

3.24

1066

5685

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

226

2.18

8.64

1.1

7.66

9.55

u/l

0.63

226

(3004451) EKG impression Narrative

396

1822

1.39

8.61

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

203

817

1.59

8.52

1.2

13.27

11.25

pmol/l

0.34

297

(3013945) Hepatitis B virus e Ab [Presence] in Serum

215

2.20

8.52

1.4

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

187

2.29

8.46

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1323

7110

1.19

8.39

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

172

668

1.65

8.33

1.4

1.3

1.18

mmol/l

0.09

172

668

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.89

8.32

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

205

2.22

8.30

1.6

2.1

9.38

7.07

nmol/l

0.14

192

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

287

1256

1.46

8.22

1.8

1.7

50543.75

16449.69

u/ml

0.43

173

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

771

3929

1.26

8.19

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.48

8.19

1.1

1.0

0.02

0.11

u/ml

0.60

(3010144) Erythrocytes [#/volume] in Synovial fluid

639

3184

1.29

8.15

1.4

99065.97

117228.72

e6/l

0.33

427

2095

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

132

2.52

8.04

1.2

1.1

674.90

340.99

u/l

0.57

111

(37021550) Renin [Units/volume] in Plasma --upright

165

641

1.65

8.00

1.3

81.49

79.22

mu/l

0.04

123

481

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

401

1874

1.37

7.98

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

317

1424

1.43

7.94

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

370

1710

1.39

7.88

1.1

1.2

18.58

9.78

u/ml

0.41

196

(3006576) Bicarbonate [Moles/volume] in Blood

240

1025

1.50

7.79

5.6

6.3

25.16

25.05

mmol/l

0.15

223

923

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

142

2.44

7.78

1.6

1.5

0.11

0.23

u/l

0.37

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

104

356

1.87

7.77

1.2

1.1

1.82

1.80

iu/ml

0.05

191

(3045462) Protein/Creatinine [Ratio] in Urine

123

444

1.77

7.77

3.4

4.3

32.50

49.82

mg/mmol

1.16

115

398

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

368

1706

1.38

7.71

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

368

1706

1.38

7.71

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

368

1706

1.38

7.71

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

306

1.93

7.50

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

367

1710

1.38

7.47

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1068

5696

1.20

7.42

1.1

0.36

0.37

u/ml

0.05

374

1685

(3010375) cycloSPORINE [Mass/volume] in Blood

337

1551

1.39

7.39

29.7

30.0

116.34

116.51

ug/l

0.01

262

1286

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

413

1966

1.35

7.35

1.6

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1168

8849

0.84

7.34

1.4

1.5

59.87

60.14

ug/l

0.07

1168

8849

(3013762) Body weight Measured

2.75

7.33

1.1

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

200

2.15

7.29

1.1

45.71

80.00

u/l

0.58

167

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

435

2094

1.33

7.20

1.6

1.4

—

(4015189) Microbial culture of sputum

183

752

1.56

7.12

2.7

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

867

1.51

7.02

1.6

0.38

0.40

ug/l

0.47

154

629

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

141

546

1.65

6.99

1.0

0.18

0.29

u/ml

0.31

333

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

372

1758

1.36

6.97

1.6

1.7

1.90

2.88

u/field

1.73

280

1256

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

120

445

1.73

6.97

1.8

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

399

1907

1.34

6.95

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

273

1225

1.43

6.95

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

273

1226

1.43

6.92

2.0

—

(3044927) Protein electrophoresis panel - Urine

592

2989

1.27

6.89

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

121

452

1.71

6.86

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

289

1.91

6.85

1.3

1.2

0.57

0.53

iu/ml

0.09

141

(3000034) Microalbumin [Mass/volume] in Urine

553

2771

1.28

6.84

3.1

3.0

52.23

56.48

mg/l

0.15

399

1972

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

132

2.38

6.77

1.0

0.14

0.06

u/ml

0.49

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

275

1243

1.42

6.74

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

796

4183

1.22

6.50

2.4

2.5

1.39

1.29

g/24h

0.43

447

2546

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2352

13455

1.12

6.47

1.5

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

286

1.88

6.46

1.2

1.1

88.38

97.79

titre

0.60

286

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.71

6.45

1.0

0.24

0.53

u/ml

0.72

(3011841) English Walnut IgE Ab [Units/volume] in Serum

100

361

1.77

6.40

1.0

0.48

1.95

u/ml

1.41

268

(3012565) Volume of 24 hour Urine

357

1702

1.34

6.37

2.0

2.2

2001.78

1993.58

0.04

325

1538

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

300

1393

1.38

6.33

2.7

2.8

159.60

142.00

au/ml

0.25

200

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

400

1942

1.32

6.31

1.4

5.72

5.57

mmol/l

1.45

377

1836

(3034426) Prothrombin time (PT)

257

1167

1.41

6.18

1.2

28.02

28.12

0.10

257

1167

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

131

516

1.63

6.14

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

255

1.91

6.13

1.0

0.98

1.27

u/ml

0.10

237

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1565

8755

1.15

6.12

1.3

—

(44806420) Estimation of glomerular filtration rate

565

4498

0.80

6.03

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

208

2.00

6.00

1.2

1.1

—

(3024263) Appearance of Synovial fluid

344

1648

1.34

5.98

1.6

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

1431

7974

1.15

5.93

3.6

3.0

1.53

1.56

mmol/l

0.65

1391

7793

(3038177) Helicobacter pylori Ab [Presence] in Serum

1171

6432

1.17

5.89

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1104

6040

1.17

5.84

1.1

1.2

1.20

1.11

0.10

296

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

111

425

1.67

5.83

1.3

1.4

44.00

53.00

0.91

216

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

125

494

1.62

5.81

1.5

1.6

6.46

263228.16

nmol/l

3.18

416

(3036071) Salmonella sp Ab [Titer] in Serum

258

1187

1.39

5.79

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

288

1.82

5.78

1.0

0.48

0.61

u/ml

0.24

159

(3016273) Islet cell 512 Ab [Units/volume] in Serum

239

1.90

5.70

1.0

—

(44806071) Cardiolipin IgM antibody measurement

127

507

1.60

5.68

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

108

414

1.67

5.66

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

602

3122

1.24

5.65

2.1

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

504

2562

1.26

5.64

1.8

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

259

1.85

5.59

1.3

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

106

406

1.67

5.58

1.0

0.35

0.27

u/ml

0.09

245

(3037692) Legionella sp identified in Specimen by Organism specific culture

246

1131

1.39

5.57

1.5

1.4

—

(3016750) Collection duration of Urine

366

1791

1.31

5.53

2.4

2.2

508.27

498.37

min

1.18

271

1358

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

316

1.76

5.52

1.1

1.73

2.88

umol/24h

0.50

316

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

342

1658

1.32

5.52

1.4

1.5

—

(3024932) HLA-DR beta [Type]

249

1150

1.39

5.49

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

141

583

1.55

5.46

2.7

2.3

7.23

7.44

mmol/l

0.24

365

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1474

8286

1.14

5.43

1.4

106.56

135.58

pmol/l

2.19

1434

8078

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

341

1658

1.32

5.40

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

319

1537

1.33

5.39

1.8

1.7

—

(3033099) Centromere Ab [Titer] in Serum

202

903

1.43

5.37

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

153

647

1.51

5.36

5.6

6.1

4220.00

6191.04

iu/ml

—

(3016228) CD19 cells/cells in Blood

287

1362

1.35

5.36

2.1

2.0

8.99

8.19

0.65

279

1332

(3002621) Streptococcal DNAse B [Units/volume] in Serum

334

1.73

5.33

1.0

1.1

420.26

308.72

u/ml

0.51

(3006442) Creatine [Moles/volume] in Serum or Plasma

465

2359

1.26

5.33

1.8

1.4

77.11

82.83

umol/l

2.88

465

2354

(3023487) Leukocytes [#/volume] in Peritoneal fluid

256

1196

1.37

5.29

2.4

1.9

3063.96

3107.28

e6/l

0.01

163

796

(3000330) Specific gravity of Urine by Test strip

2906

17021

1.10

5.17

3.5

3.3

1.02

ratio

1.81

2566

15252

(3024471) HLA-A [Type]

251

1177

1.37

5.09

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

190

1.95

5.08

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

296

1.75

5.08

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

334

1635

1.31

5.07

2.4

22.89

189.15

ug/l

1.79

315

1572

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

177

1.99

5.06

1.1

1.11

1.21

u/field

0.51

122

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

120

488

1.57

5.03

1.1

1.3

36.88

42.50

mg/l

0.72

106

414

(3002331) Protein [Mass/volume] in Peritoneal fluid

171

752

1.46

4.99

1.4

141.00

28.53

g/l

0.47

117

586

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

325

1590

1.31

4.97

3.5

3.6

8.51

8.73

mg/l

0.22

261

1290

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

183

1.96

4.95

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

300

1454

1.32

4.91

2.2

2.1

63.87

105.05

ug/min

0.82

333

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

305

1482

1.32

4.90

3.8

4.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

126

522

1.55

4.89

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

283

1361

1.33

4.89

1.1

1.0

9.19

11.16

u/ml

0.84

176

897

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

222

1028

1.38

4.88

2.1

1.8

9132.15

13218.92

e6/l

0.37

110

522

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

2.27

4.87

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.94

4.81

1.1

1.0

17.85

17.93

umol/l

0.00

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

335

1.68

4.80

1.0

0.14

0.89

u/ml

1.44

233

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

241

1.81

4.74

1.6

1.4

17.55

15.37

pmol/l

0.20

210

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

121

2.17

4.72

1.3

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

362

1.65

4.68

1.0

1.1

0.25

1.92

u/ml

1.69

269

(3003329) Lymphocytes/Leukocytes in Synovial fluid

603

3198

1.21

4.64

1.5

1.6

29.17

32.49

1.34

355

1998

(3012898) Urea [Moles/volume] in Urine

363

1.64

4.64

1.7

1.5

157.86

171.65

mmol/l

0.50

317

(40763480) Human metapneumovirus Ag [Presence] in Specimen

140

2.06

4.56

1.3

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

425

1.58

4.54

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

720

3892

1.19

4.51

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.74

4.48

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

387

1.61

4.45

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

1177

1.34

4.44

1.1

3.33

6.00

u/ml

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

196

1.86

4.39

1.1

1.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

142

619

1.47

4.39

1.1

13.32

34.87

iu/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

118

497

1.52

4.31

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2100

12230

1.10

4.28

3.2

3.7

375.62

1883.45

u/ml

2.10

1787

10582

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

273

1335

1.31

4.26

1.0

0.43

0.64

u/ml

0.74

265

1312

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.73

4.26

1.4

1.3

66.46

51.29

e6/l

0.11

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

231

1.77

4.25

1.3

1.5

43.97

37.55

0.51

161

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

161

725

1.42

4.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

202

946

1.37

4.21

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

202

946

1.37

4.21

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

202

946

1.37

4.21

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

202

946

1.37

4.21

1.2

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

106

2.17

4.21

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

122

522

1.50

4.16

6.1

5.3

48.92

42.88

ug/min

0.41

400

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

168

1.91

4.15

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.38

4.15

2.7

3.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

186

862

1.38

4.14

1.6

1.4

11.56

13.84

g/l

2.71

129

665

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

111

466

1.53

4.13

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

370

1894

1.25

4.05

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

582

3126

1.19

3.98

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

137

606

1.45

3.98

1.3

1.4

981.82

149380.32

u/ml

0.54

(40759632) Porphyrins [Mass/mass] in Stool

3.43

3.97

1.2

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

7.20

3.89

2.2

4.5

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

202

1.78

3.77

1.3

1.6

12.54

12.89

0.04

152

(3006571) Granulocytes/Leukocytes in Synovial fluid

767

4239

1.16

3.74

1.5

1.6

57.25

56.04

0.34

467

2711

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

103

437

1.51

3.70

1.0

0.70

3.15

u/ml

0.75

191

(40762365) Oxygen content in Arterial blood by calculation

112

484

1.48

3.69

3.9

2.8

14.52

14.89

ml/dl

0.70

103

452

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1619

11423

0.90

3.68

1.5

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

243

1.69

3.63

1.0

0.23

0.13

u/ml

0.19

243

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

172

1.82

3.61

1.2

1.4

0.59

1.88

2.11

121

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

224

1.72

3.61

1.0

15.59

17.70

u/ml

0.14

180

(3013166) Neutrophils/Leukocytes in Synovial fluid

195

934

1.34

3.59

1.3

1.4

53.57

54.39

0.10

162

801

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.59

3.57

1.0

0.10

0.18

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

921

6695

0.88

3.56

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.40

3.53

1.3

2.9

4.96

2.01

mu/l

0.70

(3024316) Viscosity of Plasma

155

1.86

3.52

1.6

1.7

1.62

1.57

mpas

0.18

(3042951) Complement C1q Ab [Units/volume] in Serum

165

1.82

3.48

1.2

11.87

21.86

u/ml

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.21

3.46

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

409

1.50

3.41

3.0

2.8

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

100

432

1.48

3.34

1.0

0.17

0.83

u/ml

1.24

192

(3052592) Norovirus Ag [Presence] in Stool

131

597

1.41

3.31

1.2

1.4

—

(3044007) Cell count panel - Peritoneal fluid

207

1015

1.31

3.28

2.3

1.9

—

(3018133) Calcium [Moles/volume] in Urine

156

735

1.36

3.24

1.7

2.0

2.61

2.76

mmol/l

0.41

147

674

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

4.14

3.20

1.1

110.17

28.61

umol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

316

1638

1.24

3.19

1.3

1043.28

1042.12

titre

0.00

349

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

416

1.48

3.18

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

515

0.60

3.17

6.2

1.3

7.70

7.20

mmol/l

0.47

151

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

1.68

3.16

1.0

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.19

3.06

1.0

1.2

2.88

2.81

mmol/l

0.04

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

256

1.60

3.04

1.1

24.35

24.84

u/ml

0.02

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

256

1.60

3.04

1.1

13.33

36.35

u/ml

3.20

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.27

3.03

1.2

1.1

2.65

2.71

0.04

(3011325) HIV 1+2 Ab [Presence] in Serum

159

1.77

3.01

1.1

1.0

0.09

0.08

0.29

114

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

291

1506

1.24

3.01

2.2

2.1

8.91

9.17

mg/l

0.36

243

1242

(3020393) Adenovirus Ag [Presence] in Stool

365

1.49

2.97

1.1

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

209

1.65

2.92

1.1

1.2

5.00

5.12

u/ml

0.01

171

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

175

1.72

2.92

12.8

10.5

552.86

206.60

e6/l

0.54

121

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

484

2638

1.18

2.92

1.8

1.9

2.27

2.78

u/field

0.24

280

1481

(3004775) Volume in Urine collected for unspecified duration

445

2409

1.18

2.91

2.4

2.3

699.61

670.62

0.67

324

1664

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

409

1.46

2.90

1.0

0.37

1.02

u/ml

0.53

189

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

415

1.45

2.87

1.7

1.8

1.62

1.75

mg/l

0.43

352

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

245

1.59

2.87

1.0

1.00

2.42

u/ml

0.65

197

(3042628) Porphyrins [Moles/volume] in Urine

5.12

2.86

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

102

1.95

2.83

1.0

209.50

210.48

pmol/l

0.01

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

215

1085

1.27

2.79

2.1

1.9

1.82

ratio

0.01

206

1049

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

267

1.56

2.79

1.5

1.3

1.23

1.48

ml/s/173m2

0.30

167

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

175

860

1.30

2.79

1.2

—

(3007916) DNA double strand Ab [Titer] in Serum

418

1.44

2.78

1.4

1.3

82.40

152.88

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1270

1.25

2.75

1.9

2.0

40.17

40.44

g/l

0.30

247

1270

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

253

1.57

2.75

2.3

3.3

42.61

313.07

pmol/l

0.52

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

892

5098

1.12

2.75

1.3

7.21

7.02

mmol/l

1.17

811

4509

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

560

1.37

2.71

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

194

1.65

2.71

1.2

1.3

1585.58

760.20

u/l

0.30

177

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

104

1.91

2.69

1.0

1.1

0.21

g/l

0.21

(3017704) Immunofixation for Urine

324

1719

1.21

2.68

1.5

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

428

2329

1.18

2.67

1.4

12.28

12.83

u/l

0.98

417

2249

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

110

1.86

2.60

1.0

7733.13

10017.52

ng/l

1.35

(21494890) Protein electrophoresis panel - 24 hour Urine

604

3382

1.14

2.60

1.9

2.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.95

2.59

1.0

3.71

2.94

u/ml

0.11

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

223

1.58

2.53

1.2

1.1

30.00

21.03

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

208

1.60

2.53

1.3

1.4

23.11

22.01

mmol/l

0.65

141

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1287

7548

1.09

2.44

1.8

1.7

—

(3045177) Copper [Moles/volume] in Urine

2.21

2.42

1.1

0.20

0.48

umol/l

0.81

(3020874) Milk IgE Ab [Units/volume] in Serum

488

2708

1.15

2.41

1.0

1.1

0.89

2.70

u/ml

1.70

202

823

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

356

1.44

2.41

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

137

1140

0.77

2.39

6.0

6.5

9.42

8.71

0.80

137

1140

(40761995) Spermatozoa Progressive [#/volume] in Semen

137

1140

0.77

2.39

3.0

3.3

42.25

45.02

0.89

137

1140

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

133

1.73

2.36

1.1

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

5.49

2.35

1.0

—

(40757373) Influenza virus identified in Isolate

124

598

1.33

2.33

1.7

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

178

1.62

2.31

1.5

1.7

0.75

0.70

umol/l

0.23

141

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

430

1.38

2.28

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

230

1.53

2.25

2.5

2.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

229

0.50

2.25

1.1

1.3

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.96

2.21

1.0

2.41

0.78

u/ml

0.34

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.87

2.18

7.6

8.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

110

929

0.76

2.18

1.3

1.2

58.91

68.22

ug/l

1.64

110

929

(3036048) Francisella tularensis Ab [Titer] in Serum

169

861

1.26

2.13

1.1

1.2

246.67

505.22

titre

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

270

1.47

2.12

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

431

1.37

2.11

2.5

—

(3007147) Virus identified in Stool by Electron microscopy

3.41

2.09

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

119

1.72

2.08

1.1

1.00

1.26

u/field

0.45

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

105

504

1.33

2.07

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

204

1.54

2.07

1.1

2.96

2.79

u/l

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.91

2.07

8.1

9.0

48.78

43.62

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

516

2914

1.13

2.04

1.4

1.3

159.05

189.27

pmol/l

2.14

516

2914

(3025549) Creatine [Moles/time] in 24 hour Urine

257

1.47

2.03

1.7

1.4

—

13.18

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

185

1.56

2.02

6.1

4.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

268

1.46

2.02

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.18

2.00

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.81

2.00

1.2

1.3

28.23

45.76

umol/24h

0.56

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.86

1.94

1.6

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

335

1.40

1.93

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3460

23151

0.95

1.90

1.5

1.6

1026.20

1014.77

mu/l

0.19

2812

19796

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

261

1.45

1.90

1.2

112.30

97.40

ug/l

0.30

160

(3043410) Blood group antigens tested for on Red Blood Cells

178

926

1.23

1.90

1.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

448

2521

1.14

1.90

1.5

31.20

34.97

nmol/l

1.61

393

2346

(3036670) Protein [Mass/volume] in Synovial fluid

187

981

1.22

1.85

1.3

39.10

40.41

g/l

0.66

520

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

140

712

1.26

1.84

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

394

1.35

1.81

1.0

1.1

0.84

5.26

u/ml

0.52

200

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.19

1.78

1.1

3700.43

3752.54

titre

0.02

(4094501) Cardiovascular stress test using bicycle ergometer

1645

9888

1.07

1.75

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

234

1.45

1.75

1.7

2.0

19.96

18.97

mmol/l

0.14

196

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

131

1.61

1.74

5.4

5.8

15.74

17.88

mmol/l

1.43

123

(3007456) Orange IgE Ab [Units/volume] in Serum

1.74

1.73

1.0

0.07

0.17

u/ml

0.40

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

211

1131

1.19

1.70

1.7

120.91

127.69

au/ml

0.07

164

(3034891) Synovial lining cells/cells in Synovial fluid

309

1710

1.16

1.70

1.4

1.5

3.47

4.13

0.30

375

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

142

1.58

1.70

3.3

3.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

215

1.46

1.68

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

345

1.35

1.66

1.6

1.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

164

0.51

1.66

1.0

0.83

0.32

u/ml

—

(37019676) Renin [Units/volume] in Plasma --supine

1.87

1.65

1.1

1.0

65.58

57.51

mu/l

0.07

(3019174) dRVVT (LA screen)

324

1.36

1.64

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

147

764

1.23

1.63

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

280

1545

1.16

1.62

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

147

765

1.23

1.62

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

380

1.33

1.61

2.4

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

138

714

1.24

1.60

2.3

2.1

—

(3006462) Nitrate [Presence] in Urine

286

1582

1.16

1.60

3.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

147

766

1.23

1.60

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

121

617

1.26

1.60

6.1

6.9

64.43

71.46

1.94

476

(4211845) Urine protein measurement

313

1745

1.15

1.58

2.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

387

1.32

1.58

2.5

2.3

0.65

0.61

u/field

0.12

387

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

102

511

1.28

1.56

1.6

1.7

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.80

1.55

1.0

1.1

52.71

20.25

umol/l

—

(3000285) Sodium [Moles/volume] in Blood

117

597

1.25

1.55

1.3

1.2

138.24

138.35

mmol/l

0.10

502

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1177

7033

1.07

1.54

3.1

3.6

723.10

852.49

u/ml

0.18

1054

6365

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

456

1.29

1.54

2.8

2.9

49.81

75.48

pmol/l

2.19

400

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

132

1.55

1.48

1.1

223.50

295.74

nmol/l

1.13

132

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

408

1.30

1.48

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

127

1.56

1.48

1.0

0.04

0.11

u/ml

0.52

127

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

238

1.40

1.46

1.3

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.64

1.46

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

228

1.40

1.44

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5547

34491

1.03

1.43

3.6

4.4

25.87

24.85

ug/l

0.06

4422

27653

(3003843) Paprika IgE Ab [Units/volume] in Serum

103

1.62

1.42

1.0

0.07

u/ml

0.00

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1647

9979

1.06

1.42

1.5

1.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.03

1.42

1.4

1.1

0.92

1.29

0.28

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

142

750

1.21

1.40

2.7

328.75

378.37

ug/l

0.05

142

750

(3017958) Strawberry IgE Ab [Units/volume] in Serum

119

1.56

1.39

1.0

0.06

0.14

u/ml

0.47

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

160

856

1.20

1.38

1.9

2.9

99.81

108.26

ng/l

0.32

465

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.20

1.38

1.2

1.0

8.80

0.00

u/l

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

385

0.71

1.37

1.1

1.0

1.18

1.17

mom

0.04

385

(3009677) Dengue virus Ab [Presence] in Serum

161

1.47

1.37

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

253

1.37

1.35

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

237

1.38

1.34

1.5

312.12

320.59

umol/24h

0.13

237

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

488

3437

0.91

1.30

1.5

1.6

8.09

7.60

mmol/l

5.02

466

3303

(4133840) Spirometry

138

1057

0.84

1.29

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

317

1.31

1.27

1.2

1.3

136.53

311.01

mg/24h

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

204

0.63

1.25

4.5

3.9

0.00

estimate

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

234

0.66

1.23

2.2

2.3

0.72

0.66

ug/l

0.30

234

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

260

1463

1.14

1.22

3.3

1.42

1.30

0.55

260

1463

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

155

0.58

1.22

1.0

0.75

0.44

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

259

1458

1.14

1.21

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

286

1.32

1.21

1.0

1.1

10.10

6.71

u/ml

0.49

166

(3009015) Lactate [Moles/volume] in Synovial fluid

343

1.29

1.19

1.2

1.3

5.25

6.51

mmol/l

1.20

162

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

146

1.45

1.16

9.8

9.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

142

0.59

1.10

1.0

1.06

0.77

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1905

11684

1.04

1.08

1.4

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

159

873

1.17

1.08

1.8

1.9

37.00

37.73

u/l

0.02

145

793

(3041184) Isoniazid [Presence] in Urine

2.00

1.07

2.4

2.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.00

1.07

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

1572

9603

1.05

1.07

1.5

1.27

1.26

0.60

1076

7101

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

231

1.33

1.07

4.1

5.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

248

1.32

1.06

1.0

1.1

0.42

1.61

u/ml

1.19

173

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

1.92

1.01

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

222

1.33

1.01

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

318

1.27

1.01

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.94

1.00

1.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

1.86

0.98

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

191

0.67

0.97

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

679

4065

1.07

0.96

1.9

2.0

28.98

25.03

ug/l

0.50

666

3989

(3042111) Morphology [Interpretation] in Bone marrow Narrative

900

5437

1.06

0.96

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

219

1.32

0.95

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.66

0.95

1.0

1.1

93.67

90.37

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

158

879

1.15

0.94

1.3

41.84

40.04

0.22

109

592

(3032641) Amino acids panel - Urine

1.88

0.93

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1933

11924

1.04

0.89

1.4

1.5

0.98

0.95

ratio

1.82

1094

7204

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1933

11925

1.04

0.88

1.4

1.5

1.22

1.18

ratio

1.11

1104

7269

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.90

0.88

1.0

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

505

1.19

0.88

1.5

1.6

108.47

112.64

ug/l

0.14

411

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

245

0.73

0.86

2.3

2.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

134

1.39

0.86

2.1

3.2

111085.71

78800.89

u/ml

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.02

0.86

1.3

1.2

35.83

31.26

nmol/24h

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

145

1.37

0.86

1.2

1.1

0.04

0.36

mg/l

0.52

121

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

129

1.39

0.85

2.1

3.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.50

0.84

1.2

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1925

11892

1.04

0.83

1.4

1.5

1.18

1.16

ratio

0.23

1087

7171

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.46

0.82

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

391

2311

1.08

0.82

1.8

2.0

265.64

801.70

pmol/l

0.90

343

(3034614) HLA Ag [Interpretation]

1.47

0.81

1.4

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

114

1.40

0.81

1.0

1.1

—

(3049233) Organic acids panel - Urine

1.72

0.80

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

224

1292

1.11

0.79

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

364

2151

1.08

0.78

6.5

7.3

57.53

54.72

ug/l

0.02

231

1422

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

563

3382

1.07

0.77

4.3

4.2

59.60

54.25

u/ml

0.14

555

3347

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.53

0.77

3.3

4.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1592

9823

1.04

0.76

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

127

1.36

0.75

1.3

1.23

1.15

u/field

0.17

(3007919) Fasciola sp Ab [Titer] in Serum

1.49

0.74

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.53

0.74

1.5

1.9

9.97

21.75

ng/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

118

864

0.87

0.73

1.2

1.3

285.41

249.40

ug/l

0.07

471

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.51

0.73

1.1

—

371.20

—

(40768795) Lymph node Pathology biopsy report

529

3600

0.94

0.71

1.3

1.2

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

190

1.28

0.71

1.0

1.2

—

438.57

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.47

0.70

1.6

1.4

377.41

388.84

mg/24h

0.07

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

101

1.39

0.70

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

294

1.22

0.70

1.1

1.0

0.33

0.70

u/ml

0.46

164

(3023436) Glucagon [Mass/volume] in Serum or Plasma

191

1.27

0.69

1.7

1.9

230.67

195.10

ng/l

0.50

169

(3001686) Cold agglutinin [Titer] in Serum or Plasma

109

609

1.15

0.68

1.2

1.3

58.73

359.95

titre

1.34

(3013466) aPTT in Blood by Coagulation assay

232

1.24

0.67

1.1

37.09

36.68

0.11

196

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

546

1.15

0.64

1.7

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

103

1.37

0.64

1.0

7.69

12.58

mg/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2024

12588

1.03

0.64

1.5

61.65

62.57

ug/l

0.35

1627

10575

(4212803) Bone marrow aspirate examination

257

1.22

0.64

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.43

0.63

2.9

5.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

442

2658

1.06

0.63

1.0

1.1

1.50

3.52

u/ml

0.70

141

637

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.60

0.61

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

459

1.16

0.61

1.2

1.3

6.00

5.76

mmol/l

1.70

459

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

150

0.73

0.60

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.83

0.60

1.0

2.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.41

0.60

5.8

5.4

0.20

0.24

mmol/l

0.27

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

345

2362

0.93

0.60

1.2

1.3

15.06

14.48

u/l

0.15

322

2164

(3027874) Urate [Moles/volume] in Urine

127

1.31

0.60

1.1

1.77

6.32

mmol/l

0.51

(40758292) HTLV I+II Ab panel - Serum

107

772

0.89

0.58

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

520

0.86

0.57

5.3

5.5

8.24

8.52

mmol/l

0.46

520

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

185

1.25

0.57

4.1

3.6

—

(40763590) HLA-DQ beta [Type]

145

1.28

0.57

1.0

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

1.67

0.57

1.2

1.1

137.00

67.39

umol/l

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.56

0.56

1.0

0.03

0.14

u/ml

—

(4035726) Immunohistochemistry procedure

4826

30387

1.02

0.56

1.4

—

(3045142) Bone marrow Pathology biopsy report

571

3833

0.95

0.53

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

479

3229

0.95

0.52

1.4

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

262

1797

0.93

0.51

2.2

3.62

3.69

ug/l

0.04

233

1675

(46236302) HLA-C [Type] by High resolution typing

148

1.25

0.50

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

360

1.16

0.50

1.4

1.5

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.60

0.50

1.1

2.9

—

(3010937) Rubella virus Ab [Presence] in Serum

271

1.18

0.50

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

126

729

1.11

0.50

1.3

1.2

82.76

56.60

mg/l

0.25

501

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

137

0.75

0.49

1.1

—

(40762814) Titanium [Mass/volume] in Blood

498

0.87

0.49

2.6

2.5

4.08

3.55

ug/l

0.22

190

(3025886) Oxalate [Mass/time] in 24 hour Urine

115

0.72

0.49

1.1

1.3

39.05

31.81

mg/24h

0.45

115

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.40

0.49

1.0

0.45

0.48

u/ml

0.02

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

132

1.26

0.48

1.2

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.49

0.46

1.0

1.1

1108.00

2192.09

titre

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

262

1572

1.07

0.46

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

551

1.12

0.45

1.4

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

168

1.22

0.45

1.0

1.1

0.01

1.23

u/ml

1.92

168

(3003157) Bacteria [#/volume] in Mother's milk

0.70

0.44

8.1

6.6

—

(3029612) Listeria sp Ab [Titer] in Serum

1.35

0.44

1.3

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

136

949

0.92

0.43

1.3

4.59

3.27

mmol/l

2.68

125

875

(3020618) Glucose [Moles/volume] in Synovial fluid

117

1.26

0.43

1.1

4.97

5.00

mmol/l

0.02

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.4

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.71

0.42

2.3

1.4

6.36

8.99

mg/l

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.40

0.42

1.3

1.4

0.60

0.68

u/field

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

1.52

0.41

1.0

1.2

41.40

30.67

ug/l

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

100

705

0.91

0.41

1.4

30.78

22.66

1.61

580

(40760409) HLA-A [Type] by High resolution

147

1.22

0.40

1.0

—

(40760410) HLA-B [Type] by High resolution

147

1.22

0.40

1.0

—

(3022670) pH of Venous cord blood

1.36

0.40

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

165

1.20

0.40

1.2

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.37

0.39

1.9

2.6

—

(3013862) HLA-DP [Type]

148

1.21

0.38

1.0

—

(44786800) Granulocytes/Leukocytes in Body fluid

327

1.14

0.38

1.2

1.3

28.02

24.99

0.25

252

(3020650) Glucose [Presence] in Urine

226

1362

1.06

0.37

1.6

0.03

0.05

estimate

0.49

226

1362

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.31

0.37

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.31

0.37

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.31

0.37

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.31

0.37

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.31

0.37

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.31

0.37

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

340

1.13

0.37

1.2

0.07

0.35

u/ml

1.63

(3022475) Manganese [Moles/volume] in Blood

214

1.17

0.37

1.1

1.3

0.16

umol/l

0.52

214

(3051387) C reactive protein [Mass/volume] in Capillary blood

1152

7189

1.03

0.37

4.2

3.2

24.49

26.91

mg/l

1.47

777

4913

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

586

0.91

0.36

5.8

6.7

10.44

10.66

0.36

586

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

353

1.12

0.36

2.9

3.0

1.22

1.33

mg/l

0.21

240

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

305

1.13

0.36

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

396

2645

0.96

0.35

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

221

1335

1.06

0.35

2.9

3.1

—

(3038515) Glucose [Moles/volume] in Venous blood

1071

6686

1.03

0.34

4.0

3.2

7.44

7.52

mmol/l

0.36

1039

6543

(3035611) Eosinophils/Leukocytes in Synovial fluid

205

1.16

0.32

1.6

1.7

0.68

0.66

0.02

160

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

886

5526

1.03

0.32

3.8

3.7

29.64

39.62

u/ml

2.27

853

5336

(3025577) Chromium [Mass/volume] in Blood

259

1740

0.95

0.31

2.2

2.44

2.35

ug/l

0.09

207

1462

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

230

0.86

0.31

4.0

5.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2323

15091

0.98

0.30

1.4

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

449

2976

0.97

0.30

1.3

590.62

481.67

u/l

0.65

423

2821

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

451

0.91

0.29

1.3

102.92

217.91

u/l

0.47

315

(3045788) Cell count panel - Pleural fluid

505

3129

1.03

0.29

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

1193

7793

0.98

0.29

4.8

3.9

—

(40765096) Chromosome analysis panel by Banding

149

1013

0.94

0.29

1.1

1.2

—

(3014891) Appearance of Pleural fluid

396

0.91

0.28

1.8

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

468

2901

1.03

0.27

1.1

19.30

19.12

u/ml

0.03

175

1215

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.22

0.27

1.4

1.3

6.94

16.21

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

620

3861

1.03

0.27

1.5

4413.09

3236.47

e6/l

0.59

429

2717

(3012989) Citrate [Moles/time] in 24 hour Urine

1.22

0.25

1.3

1.5

1.61

2.12

mmol/24h

1.05

(3021162) Amylase [Enzymatic activity/volume] in Specimen

579

1.07

0.25

3.6

2.7

1824.76

1556.66

u/l

0.14

516

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.33

0.23

1.2

1.0

0.90

u/ml

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

4.68

1.88

u/ml

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

108

0.83

0.22

1.0

—

(3009992) Blasts/cells in Bone marrow

1.23

0.22

1.2

1.9

17.00

17.54

—

(3009871) Measles virus Ab [Titer] in Serum

250

1541

1.04

0.22

1.7

1.6

2645.93

3600.33

titre

1.17

267

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

329

1.09

0.22

1.0

1.1

23.08

20.95

u/l

0.32

211

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.8

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.24

0.21

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.24

0.21

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

497

3262

0.97

0.21

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

309

0.91

0.21

1.1

17.73

17.30

g/l

0.13

281

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.28

0.21

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

434

0.93

0.20

1.2

1.5

—

(4281824) Cell count and differential, peritoneal fluid

583

3814

0.98

0.20

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

926

6028

0.98

0.19

3.4

3.3

0.82

0.80

nmol/l

0.49

724

4854

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

446

0.93

0.19

1.3

1.4

10.94

12.41

0.17

231

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

456

1.07

0.19

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

456

1.07

0.19

8.4

8.6

0.37

0.39

umol/l

0.17

412

(3028308) Erythrocytes [#/volume] in Pleural fluid

546

3421

1.02

0.18

1.5

1.4

50953.12

50966.89

e6/l

0.00

296

1951

(3035285) Chloride [Moles/volume] in Venous blood

580

3637

1.02

0.18

2.8

2.3

105.52

105.60

mmol/l

0.15

580

3604

(3041918) Cholesterol [Moles/volume] in Pleural fluid

628

0.95

0.17

1.2

1.72

1.65

mmol/l

0.21

387

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.17

0.17

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

235

1.09

0.17

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

444

2779

1.02

0.17

1.8

3.96

3.70

mg/l

0.49

423

2669

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.16

0.17

1.1

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

143

1.12

0.16

1.1

1599.60

4825.50

ng/l

1.63

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.75

0.16

1.2

79.83

81.60

—

(3041354) Potassium [Moles/volume] in Venous blood

579

3639

1.02

0.16

2.8

2.3

4.01

4.05

mmol/l

1.38

579

3606

(3044416) Complement C4 [Mass/volume] in Pleural fluid

144

1.11

0.15

1.1

1.2

0.10

0.07

g/l

0.46

101

(40758358) Immune stain study

138

1.11

0.15

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1262

7987

1.01

0.14

1.1

—

(21494434) Karyotype in Bone marrow

464

2914

1.02

0.14

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

250

1.08

0.14

1.1

5.44

18.38

iu/ml

—

(3035082) Kappa light chains [Mass/volume] in Urine

102

1.13

0.14

1.1

0.04

0.12

g/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

145

1.10

0.14

1.6

1.4

—

(3001729) Color of Synovial fluid

246

1.07

0.12

1.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

215

1.07

0.11

1.0

0.54

7.34

u/ml

0.49

104

(3033705) Calcium.ionized [Moles/volume] in Venous blood

553

3590

0.99

0.11

2.9

2.3

1.20

mmol/l

0.03

553

3557

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

351

0.95

0.11

1.4

65.87

72.20

0.65

288

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

297

1864

1.02

0.11

1.9

1.8

2.36

2.89

u/ml

0.25

527

(3035880) pH of Pleural fluid

249

1628

0.98

0.11

1.2

1.3

7.36

7.41

2.54

168

1156

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

172

1.08

0.11

11.6

13.1

108.69

105.65

g/l

0.58

172

(3003740) Influenza virus B Ag [Presence] in Specimen

1258

7985

1.01

0.10

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.03

0.09

1.2

1.0

—

(3006598) pH of Arterial cord blood

1.12

0.09

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3189

20323

1.00

0.08

1.7

1.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

163

1021

1.02

0.08

1.4

58.38

62.95

0.91

139

836

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.11

0.07

1.3

1.2

20.71

30.34

mg/l

1.65

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

586

0.97

0.07

1.0

12.17

8.29

u/ml

0.38

586

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

143

896

1.02

0.07

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

534

0.97

0.07

1.2

1.3

1.22

1.36

mmol/l

0.13

341

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

150

1.07

0.07

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.83

0.07

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.09

0.07

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

394

2496

1.01

0.06

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

183

1.05

0.05

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

107

671

1.02

0.05

2.3

1.8

2.17

3.42

ug/l

0.84

424

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

240

1.04

0.05

1.1

—

(4038314) Semen analysis, post vasectomy

350

0.97

0.05

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

133

865

0.98

0.05

1.0

1.1

22.71

29.46

iu/ml

1.06

133

865

(3000919) Neutrophils/Leukocytes in Pleural fluid

124

782

1.01

0.04

1.4

26.13

20.84

1.20

115

703

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

299

1900

1.01

0.03

1.2

9.68

9.54

mm/h

0.08

299

1900

(3003434) Protein [Mass/volume] in Pleural fluid

675

4338

1.00

0.03

1.5

1.4

78.97

33.00

g/l

0.52

615

3932

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

230

0.97

0.02

2.6

2.2

12.11

17.32

0.48

112

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.06

0.02

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

230

1481

0.99

0.02

1.6

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

496

3185

1.00

0.02

1.3

6.44

6.25

mmol/l

0.76

454

2970

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

139

883

1.01

0.01

7.2

8.2

6.06

5.94

kpa

0.86

123

788

(3038071) Oxygen [Partial pressure] in Mixed venous blood

122

787

0.99

0.01

7.3

8.1

5.74

5.69

kpa

0.07

122

787

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

184

0.97

0.01

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.04

0.01

1.1

0.03

0.08

g/l

—

(3048879) Bone marrow aspiration report

136

865

1.01

0.01

1.8

2.00

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

387

2471

1.00

0.01

1.0

0.55

0.89

u/ml

0.52

135

553

(3018291) Platelet Ab [Presence] in Serum

1.07

0.01

1.0

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

862

0.99

0.00

1.4

3.32

2.75

0.37

118

723

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

284

1.01

0.00

2.5

2.2

46.12

60.63

1.65

175

(3007542) Rye IgE Ab [Units/volume] in Serum

246

1.01

0.00

1.0

0.82

8.59

u/ml

0.47

108

(3018738) Hemoglobin F/Hemoglobin.total in Blood

245

0.99

0.00

3.2

3.0

27.94

10.44

2.22

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.01

0.00

2.4

2.1

28.20

27.53

0.07

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.99

0.00

1.2

1.1

232.20

277.55

u/ml

0.50

(3042301) Urate [Moles/volume] in Synovial fluid

1.05

0.00

1.0

448.20

357.97

umol/l

—

(3003577) Lead [Moles/volume] in Blood

330

0.99

0.00

1.3

1.5

0.44

0.32

umol/l

0.32

108

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

232

0.99

0.00

1.0

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.7

—

4.73

—

(3006906) Calcium [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

2.42

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.86

-0.00

1.2

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_MOOD – Mood [affective] disorders

GWS hits: 42

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mood [affective] disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints